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Chapter 1 
 
 
The Literature Review  
 
Introduction. 
It is the governments intent to modernise the NHS. One of the 
methods in which this can be achieved is through evidence based 
practice. The current climate within the NHS has clear manifestations 
of such practice, the most visible perhaps being the increase in audit 
within practice. The facilitation of high quality care also requires 
practitioners to partake in multiprofessional treatment planning and 
embrace such plans into their every day practice. In line with the 
above it is essential that during the emergence of such practice audit 
occurs to measure the effectiveness of such approaches.  
 
One of the areas that could greatly benefit from such practice is that 
of Cerebral Palsy. Management of children with cerebral palsy is the 
focus of considerable resources in many countries so that the 
evaluation of the efficacy of new and established treatments is 
imperative (Boyd 2001).      
Cerebral Palsy is a lifelong condition with a significant impact on the 
individual and their carers. Most subjects with mild or moderately 
severe CP survive into adult life and have a normal life expectancy 
(Bhusan 1993). Although the brain pathology that underlies the clinical 
manifestations of CP is non-progressive, the functional abilities of the 
individuals and their health and social needs usually change (Bakheit 
2001).  
With the above philosophy of evidence based practice in mind and the 
current need for valid and reliable tools to achieve this goal, it is the 
aim of this thesis to validate an activity monitor, the activPAL, for use 
with cerebral palsy (CP). It will establish whether or not the activPAL 
activity monitor is a valid and reliable tool with which to measure this 
population. A review of existing activity monitor research shall take 
place and outcome measures currently adopted within cerebral palsy 
studies shall be reviewed.  
It is proposed that the activPAL activity monitor could be used as an 
alternative outcome measure within treatment regimes. This may 
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prove to provide a potential improvement over current outcome 
measures, as it collects real world data, collected in the community 
outwith the remit of laboratory conditions.     
 
1.1 CEREBRAL PALSY  
Aetiology 
 
Cerebral Palsy (CP) is the most common cause of physical disability in 
children, with a reported incidence of 2.0-2.5 per 1000 live births 
(Stanley 2000). It is also the most common motor disorder originating 
in childhood (Molnar 1991). CP results from a permanent static lesion 
of the cerebral motor cortex that occurs before, at, or within two years 
of birth (Dabney 1997). Even though the lesion itself does not change, 
the clinical manifestations of the lesion change as the child grows and 
develops (Essex 2003).Functional capacity is reduced due to a 
reduction in central control and co-ordination. The lack of central 
control is evidenced clinically by the presence of spasticity (spasticity is 
velocity dependent resistance of a muscle when stretched), which may 
lead to muscle contractures and resultant joint deformity. Weakness 
and loss of selective motor control manifests itself through poor co-
ordination. The presence of all, or combinations of the above have a 
profound effect on the individual’s ability to walk, evidenced in varying 
degrees of spatial and temporal changes in the gait cycle.  Flett 2003 
summarises the above by stating that CP is not the result of a 
recognised progressive or degenerative brain disease and is 
characterised by aberrant control of movement or posture appearing 
early in life secondary to central nervous system damage or 
dysfunction.  The motor skills of most children with CP improve as 
they grow, but the rate of improvement is slower in children with CP 
than in unaffected children (Essex 2003).                         
 
Classification of Cerebral Palsy    
Cerebral Palsy can be classified in three distinct ways, motor type, 
topographical distribution and functional severity (Stanley 2000). 
Motor Disorder 
1) Spastic Paresis-High tone that results in restriction in range of 
movement of joints. 
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2) Ataxic Paresis – results in balance difficulties and uncoordinated 
movements. 
3) Athetoid – fluctuation of tone which results in difficulties in 
control of speech and breathing. 
4) Mixed- a combination of two or more of the above. 
 
Difficulties lie in the fact that many children have mixed motor types 
and changing motor types that do not lie perfectly within the 
categories above.   
 
Topographical – the area of the body affected (Flett 2003, Levitt 
1982). 
1) Monoplegia – only one extremity/limb involved 
2) Diplegia – all four limbs involved the two lower limbs affected 
the most. 
3) Paraplegia – involvement of the lower limbs. 
4) Hemiplegia – one lower and one upper limb involved on the 
same side.           
5) Triplegia – three limbs involved with inclusion of the trunk. 
6) Quadraplegia – all four limbs involved with the trunk.                     
7) Double Hemiplegia/Spastic Tetraplegia – involvement of all four 
limbs where the involvement of the upper limbs is more severely 
affected than the lower limbs.  
 
The distribution of the most common clinical patterns is difficult to 
assess because specific diagnoses are not available. National registries 
identify CP with the code 343.9 from the International Classification of 
Diseases ninth revision (ICD9). Rumeau- Rouquette et al (1997) 
identified the distribution of clinical patterns as, hemiplegia 21%, 
diplegia 17% and quadriplegia 40%. The gross motor functional 
classification system was employed by Kennes et al (2002) and found 
the following distribution; level 1 27.5%, level 2 11.5%, level 3 
19.9%, level 4 20.1 % and level 5 21.1%. Level 1 indicates a few 
limitations and level 5 severe impairments within this classification 
system.                  
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Motor type and topographical classifications lack reliability despite 
being widely used and clinically significant. Topographical classification 
using the terms, monoplegia, diplegia, quadraplegia  is widely 
employed (Howard 2005) however confusion may exist even when 
observers are experienced due to a lack of clarity in definition, 
particularly between the less commonly used terms of double 
hemiplegia and spastic tetraplegia (Blair et al 1985). It is thought that 
the best way to classify children with CP is with a combination of 
motor type, topography and gross motor function (GMF) (Howard 
2005). It has also been stated that the GMF has strong correlations 
with musculoskeletal problems (Kennes et al 2002).  
 
 
1.2 Gait Classification in Cerebral Palsy. 
 
“Gait patterns in spastic motor disorders have been described by a 
number of authors but only two classifications are widely used,” 
(Rodda et al 2001).   
According to Winters et al 1987 there are four differentiable gait 
patterns within hemiplegia when the limb as a whole is considered and 
according to Sutherland et al (1993) there are four definable 
categories within spastic diplegia in relation to the knee motion that 
occurs. As this study is only concerned with the validation of the 
activPAL activity monitor for hemiplegic gait, Winters classification 
shall be employed within the study. There is widespread use of this 
classification and it is frequently referenced within literature (Rodda et 
al 2001).               
Winters and Gage classifications are more accurately referred to as 
postural patterns rather than gait patterns. The postural patterns are 
most clearly seen in the middle to end of stance phase and are largely 
based on sagittal plane observations except where referring to type 4 
hemiplegia and also in diplegia and quadriplegia where coronal and 
transverse plane observations are also required. Of the four types of 
Winters and Gage hemiplegia the study will look at type 2 hemiplegia. 
Type two hemiplegia can be further classified into type 2a and 2b 
where; 
Type 2a Equinus plus neutral knee and extended hip. 
Type 2b Equinus plus recurvatum knee and extended hip. 
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Type 2 hemiplegia is by far the most common type in clinical practice, 
it is characterised by a variable degree of plantarflexion during swing 
phase due to the impaired function of tibialis anterior and true equinus 
as a result of spasticity and/or contracture during the stance phase of 
gait (Rodda et al 2001).             
Apart from the rare exceptions of youngsters with severe damage to 
the brain, children with congenital hemiplegia are generally 4 to six 
months behind in early motor achievements. Attainment of walking 
may be delayed somewhat longer, but the majority can walk by 2 
years and virtually all by the age of 3. Along with the delay in motor 
achievements underdevelopment of the extremity (size and length 
discrepancy) often exists due to a cortical sensory deficit (Gage 1991).      
The recent development of the Gross Motor Function Classification 
System (GMFCS) that was designed for the measure of function has 
increasingly become used as a classification system (Howard J et al). 
This will be discussed in greater detail within the following chapters.        
 
1.3 Gait Analysis Descriptors and their relevancy to activity monitoring. 
 
In previous research to validate an activity monitor D J Walker et al 
(1997) stated that, “analysis of output from the machine in terms of 
steps counted has caused some problems of definition as shown by 
the inter-observer differences in viewing the video. At some point a 
shuffle has to be defined as a step or not. Our definition of a step has 
proved reasonably robust for the populations we have tested. The 
above comments made by Walker et al (1997) draws attention to the 
fact that inter-observer differences may exist in the way in which a 
step is defined. The above point will need to be taken into account in 
the research trial protocol. 
The challenge of defining abnormal walking patterns was raised as 
early as 1987 by Wall. The paper considers the applicability of 
standard gait descriptives as applied within the normal gait cycle when 
addressing the many variants observed within pathological gait cycles. 
It highlights some of the major difficulties encountered.  
The above paper has implications towards this study. It is apparent 
that the parameters that the activity monitor uses to identify a step 
may not be relevant when considering a person with a hemiplegic gait 
pattern resultant from C.P. The idea that the parameters and the 
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algorithms will have to be tuned for a specific clearly defined pattern 
of gait may become apparent. On further reflection on the paper and 
the pathological patterns described within. It is easy to see how the 
written word in subjective descriptions of pathological gait patterns 
can be misleading.  The subjective commentary alone is not sufficient 
to accurately transfer a true representation of the anomalies existing. 
The terminology used can be interpreted in many different ways when 
unsupported. However when supported by diagrams and video data 
for example the standard terminology can convey the gait pattern with 
more accuracy or can be less open to misinterpretation. 
 
1.4 OUTCOME MEASUREMENTS IN CEREBRAL PALSY. 
 
A major challenge to for those working with young disabled children is 
how to assess the effectiveness of various intervention programmes 
(Bax 1985). On looking further it became evident that many of the 
theories used in the treatment of CP were indeed just that, and very 
little if any research to validate particular treatment regimes was 
available. Pearson (1982) states that parents and professionals invest 
time and costly resources in diverse therapy and educational 
endeavors, but there is a lack of scientific evidence about the influence 
of various approaches on outcome. This comment was made some 
time ago now but still holds true. This is an increasing source of 
frustration for many health care professionals who recognise this as 
being the case yet find themselves without the time or the resources 
to alter the course of this historical situation.  The call for more refined 
research was made by Shonkoff and Hauser-Cram (1987), to identify 
clearly what were important programme components. Anyone who has 
worked amongst the plethora of treatment modalities within the area 
of C.P. alone will appreciate the magnitude of this request. Due to the 
long standing history of poor funding within this area very little 
research has occurred and the quality of existing research, or perhaps 
the relevancy of research to actual clinical practice is debatable.   
Helders in 2001 stated that, “The focus of paediatric rehabilitation is 
increasingly changing. The emphasis on outcome measurement is the 
driving force for redesigning service provision, as outcome tells us 
‘what’, while service provision ‘how’ is to be provided.”   
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With the advent of the modern day activity monitor the possibility of 
real world outcome measurement and resultant intervention 
assessment may become a reality.  
One of the most recent treatment advances for cerebral palsy has 
occurred through the administration of botulinum toxin A. Botulinum 
toxin is injected locally into a specific muscle or muscle groups to 
lower the spasticity within that specific injection site. This being a 
recent treatment modality it was thought pertinent to review the most 
recent (1990 – 2005) research literature to ascertain what outcome 
measures have been employed. 
A systematic review in 2001 by Boyd et al revealed that much research 
has occurred within this area over the last 15 years. However out of 
156 papers relating to the lower limb, reviewed from the last 10 years, 
only ten were randomised studies. Out of the 156 papers only five 
considered functional improvement as one of the outcome measures. 
This could be potentially due to the fact that a valid or reliable 
measurement tool doesn’t exist or that the existing measurement tools 
are impractical and time consuming in there deployment. Or is it due 
to functional improvement still not being seen as a relevant clinical 
indicator?           
 
Outcome Measures Employed in the Treatment of CP with Botulinum 
Toxin A.    
 
Gross Motor Function Classification system (GMFCS) 
 
The most useful development in the classification of CP in recent years 
has been the Gross Motor Function Classification system (GMFCS) 
(Palisano 1997). It has been shown to be both valid and reliable and 
clinically relevant for children with CP between the ages of 2 and 12 
years (Wood E. 2000). The GMFCS relies on the assessment of self- 
initiated movement with specific emphasis being placed upon function 
during sitting standing and walking. There are five levels of distinction 
within the scale based upon functional limitations, such as the ability 
to walk with and without aids and quality of movement. According to 
Howard et al 2005, children with spastic hemiplegia will usually be in 
levels one and two, whilst children with spastic diplegia will be in 
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levels 2, 3 and 4 and those with quadriplegia will be in levels 3, 4 and 
5. 
 
The gross motor function measure (GMFM)  
 
The gross motor function measure (GMFM) is a standardised 
observational instrument designed to measure changes in functional 
tasks (Russel et al 1989), it must not be confused with the qualitative 
measure of functional skills such as the gross motor performance 
measure (Palisano et al 1997). Limitations however exist with the use 
of GMFM. Damiano et al 1996 reported a ceiling effect when 
measuring outcomes in children with hemiplegia and mild diplegia. 
This effectively meant that the GMFM indicated greater improvement 
in function than was the case within this trial that looked at the 
relationship of gait analysis to GMF. In a later study in 2000, it was 
proposed by Nordmark et al that a floor effect was exhibited in groups 
with severe impairment (GMFCS 4 and 5) when measured with GMFM. 
Also younger children may be less likely to co-operate with the 
demanding testing protocol of the GMFM where 5 years is 
recommended as the suitable age for assessment (Russell et al 1993). 
Russell improved the scaling of the GMFM and provided evidence for 
its reliability and validity in 2000 (Russell 2000).              
 
Other Outcome Measurements Employed in Botulinum Toxin A Studies 
includes the physicians rating scale and kinematic studies that gain 
objective measures of gait.                        
Measurements that quantify impairment have also been used such as 
the Modified Tardieu Scale (Boyd and Graham 1999) and the Modified 
Ashworth Scale (Corry et al 1998).   
 
Questionnaire based activity monitoring designs have also been 
employed, examples of which include the Rivermead Mobility Index. 
This involves questions such as, ‘do you walk around outside without 
help?’ The weakness with this question is that it ignores the frequency 
or the duration of the activity.  
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1.5 METHODS OF ASSESSMENT FOR CHILDREN WITH CEREBRAL 
PALSY. 
 
Static Assessment 
 
One of the simplest ways the clinician has to assess CP is the static 
examination. Range of movement and muscle power are mainly of 
concern within this assessment. In a recent study (Noonan 2003) it 
was found that the average variability in static range of motion from 
physical examination ranged from 25 degrees to 50 degrees. 
 
Simple Dynamic Assessment 
 
In the simplest form a dynamic assessment will consist of the clinician 
simply observing the patient as they walk up and down (Coleman 
1999). This technique when performed by a skilled clinician can be 
useful, however the accuracy of observations made becomes more 
and more questionable as the complexity and number of gait 
deviations increase. This is also a problematic technique as the 
recording of the information is reliant on the subjective reporting of 
the clinician. Observational gait analysis can be greatly enhanced by 
the use of two dimensional video recording, especially if there is the 
facility for slow motion replay (Boyd et al 1999). The gait pattern can 
then be observed at a later date in greater detail. This recording could 
also be used for comparative purposes after treatment interventions 
and provide a simple form of outcome measure.                   
 
Gait Laboratory Assessment. 
 
As an adjunct to the static assessment, some clinical centers may have 
the added benefit of gait laboratory analysis, although this is not 
commonly the case.  
A gait laboratory provides the clinician with the possibility of greater 
accuracy of measurements. It also enables the measurement of 
parameters that would otherwise not be available, such as ground 
reaction vectors and centre of mass. 
Research has been undertaken to study the consistency of results 
gained through gait analysis. The average variability in sagittal, 
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coronal and transverse plane kinematic motions averaged 12, 7 and 
20 degrees respectively (Noonan 2003). From this it was concluded 
that substantial variations in raw data exist when the same CP patient 
is evaluated at different gait centers. Also the data do not yield the 
same treatment recommendations in the majority of patients (Noonan 
2003). The above findings perhaps point to the use of alternative 
technology as an adjunct to refine the data obtained from gait labs. It 
could also be implied that such laboratories are still complex in there 
usage and lead to erroneous results and misinterpretation, except to 
those who regularly use such equipment. This being the case a less 
complex tool is still required to help the clinician decide upon the 
validity of their treatment. 
 
When studies within gait labs use a univariate approach, where only 
one variable is measured (such as peak knee flexion) one has to 
understand that there are shortcomings in terms of specificity and 
interdependence. Variables that are specific give information about an 
isolated aspect of gait, but fail to adequately explain the whole picture 
(Novacheck et al 2004). Researchers may try to provide a more 
comprehensive picture by taking multiple and simultaneous univariate 
measures, however may fail to take into account possible 
interdependence of the recorded gait measures. As a result the same 
variable is effectively counted twice which may enhance the outcome 
artificially. Clearly great care is required when both undertaking and 
using univariate studies to draw conclusions upon treatment effects. 
This effect can be overcome by using the normalicy index (NI), a 
figure resultant from multivariate analysis of the variables, which 
provides a valuable measure for overall gait pathology based on 
quantitative gait analysis.                
 
1.6 ACTIVITY MONITORING 
 
1.6.1 Method of Activity Monitoring Previous to the Advent of Activity 
Monitors. 
 
In 1999 Coleman stated that, “the extent to which a person is able or 
willing to move around the world is often a strong indicator of his/her 
condition,” and as such can be taken as an assertion that activity is 
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worthy of assessment and an indicator of the condition and hence a 
potential outcome indicator. Quantitative evaluation of function, in 
relation to children with physical disabilities, has to date been mainly 
focused upon laboratory-based measures. However a more direct 
relationship with physical function, health and well-being may be 
found through the measurement of activity in the community (Pirpiris 
et al 2004). Previous to the advent of activity monitors this has been 
done by the employment of diaries and the employment of activity 
scales.    
 
The Employment of Diaries for the Recording of Activity. 
  
Before the advent of the modern activity monitor which produces 
quantitative data, physical activity was measured using various 
qualitative procedures. Subjects were asked to keep diaries of there 
activities over a period of time. This qualitative reporting was then 
examined to provide an indicator of the subjects real world activity. 
The accuracy of the information provided from the subject is 
questionable. This is more so the case, where patient diaries are kept 
and used by the healthcare professional, as an indicator towards a 
treatment modalities success. 
 
The Employment of Activity Scales for the Assessment of Activity. 
  
These assessments can be categorised as clinimetry and have their 
origin in clinical practice and commonly have a degree of subjectivity 
(Bussmann et al 1998). They include activity scales which have been 
devised for the measurement of physical ability/activity. All such 
activity scales are instruments and as such need to be evaluated for 
there validity and reliability.  
 
1.6.2 The measurement of activity in children. 
 
Functional assessment of a child is an effort to systematically describe 
and measure a child’s abilities and limitations when performing the 
activities of daily living. It is imperative that the tool effectively defines 
and measures the relevant construct that is function rather than 
development (McCabe et al 1990). The need to assess physical activity 
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in any population is based on the desire to determine the current 
activity status of that population. Some of the most widely used 
children’s activity measures are described below.     
 
The Paediatric Functional Independence Scale (WeeFIM) was designed 
by McCabe and is a direct descendent of the (FIM), the Adult 
Functional Independence Scale. Within this research, the scale failed 
within the third phase of ‘conceptual adequacy of its subdomaines, 
according to the method of indexing content validity described by Lynn 
(1986). Its validity as a scale is therefore questionable.       
 
The gross motor function measure (GMFM) as discussed earlier is a 
standardised observational instrument designed to measure changes 
in functional tasks (Russel et al 1989) and as such does not quantify 
the frequency of activity that occurs in the real world.   
Such a scale exists in the Childrens Activiity Scale (CARS).   
 
The Children’s Activity Rating Scale (CARS) is a rating scale that was 
developed to provide an activity score representative of energy 
expenditure in young children (Puhl, J et al 1990). Common activities 
by preschool aged children are classified into five levels according to a 
rating system developed by Puhi et al. The level 1 activities are 
sedentary. The level 2 activities are sedentary but include movement 
of the limbs or torso. Level 3 to 5 activities are labeled as translocation 
(moving the body from one location to another). The speed or 
intensity of the activities determines the level. By using the coding 
rules by Puhl et al  a level of physical activity observed for 3-s duration 
or repeated in brief duration (<3 s) at least three times within 15 s are 
recorded using a standard score sheet. Only one activity at each level 
is recorded, with up to five scores being recorded within each mm. All 
levels within the minute were then averaged, and the mean minute 
CARS score was recorded. It has been used successfully to describe 
physical activity in young children from different ethnic groups, 
although direct observation is accepted as the standard in this age 
group. Due to the high level of observation required the assessment is 
costly and there is a possibility of observer error due to the lengthy 
observation periods. 
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The ‘Activites Scale for kids (ASK)’ is a self report measure of 
childhood disability in the community, that has excellent reliability (ICC 
= 0.97) Young (2000). It is valid and responsive for children in the 
age range of 5 to 15 years old and is assessed by mail. Rasch analyses 
confirmed that all items measured the same construct and supported 
aggregation of a summary score. A correlation of 0.92 (p<0.0001) was 
demonstrated against the Childhood Health Assessment Questionnaire 
scores.  
Other childrens scales exist such as The Childhood Health Assessment 
Questionnaire (CHAQ) which was designed for children with arthritic 
conditions and the Paediatric Evaluation of Disability Inventory (PEDI) 
Feldman (1990).   
 
1.6.3 Theory of Pedometers and Accelerometers used in Activity 
Monitoring.  
 
One of the earliest forms of commercial activity monitor was the 
pedometer.  Pedometers were found to have large errors in accuracy, 
they employed a gear driven mechanical technology and were 
designed to measure distance walked (Montoye 1988). Later 
pedometers became more complex employing a horizontal, spring 
levered pendulum arm that moves up and down with vertical 
accelerations to measure the number of steps. Where displacement of 
the arm is sufficient it makes an electrical contact with a sensor and 
registers a step. Pedometers have been shown to underestimate the 
number of steps by approximately 50 – 90% at the slowest walking 
speeds of between 50-54m/min or approximately 1.8- 2.0mph 
(Schneider 2003). As early as 1976 Morris describes using 
accelerometers to measure human body movements. 
 
1.6.4 Activity Monitors and the Assessment of Activity. 
 
McDonald et al (2000) have demonstrated how the activity monitors 
have progressed to the stage where they can be used to gain effective 
objective data from children with disabilities undergoing treatment. 
The technology has moved forwards steadily to the point where the 
physical size of the activity monitor is small enough and light enough 
to capture data without affecting the daily routine, being the size of an 
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average pager. The data can also be stored “onboard” for periods up 
to 4 days and then downloaded conveniently onto a pc or laptop.  
Activity monitors have many advantages over existing forms of activity 
monitoring, being able to measure ‘real world activity’ as opposed to 
activity that occurs within the confines of the laboratory. The collection 
of data occurs over days rather than minutes, or at best hours as in 
previous methods. Their uses include assessing compliance within 
treatment regimes and as outcome measures in the evaluation of 
treatment.  A description of the activity monitor to be validated within 
this study follows below and descriptions of other commercially 
available monitors can be seen in appendix 1.    
 
The activPAL activity monitor. 
 
The activPAL activity monitor is an extremely small, slim and hence 
unobtrusive device. It can thus be attached to a patient without 
affecting their usual daily activities (see fig 1 below).   
 
 Memory capacity: 
4Mbytes  
 Weight 20g  
 Sampling frequency 
10Hz 
Specifications. 
 measurements are 
35mm x 53mm x 7mm 
 
(Figure 1 The activPAL activity monitor activaPAL information booklet)  
The activPAL activity monitor is worn on the mid line of the thigh 
halfway between the knee and the top of the leg, it is orientated as 
indicated by a figure on the front panel of the device. The device can 
be secured with Medipore tape. The device will record up to 110 hours 
with a maximum of eight sessions in the recording period. On 
completion of testing the device is switched off and attached to the 
USB port of a laptop or computer via a docking port with cable 
interface. The docking port allows for the recharging of the monitor.   
The computer communicates with the monitor via custom written 
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software which is supplied with the activity monitor. The interface and 
software make the downloading of the information an extremely easy 
and efficient process. The software displays the information in excel 
format and also provides two further formats to convey the data in a 
clear and accurate way. An example of the output can be seen below. 
Summaries of the activity record are given at the top of the window 
(total time sitting/lying, standing and stepping and the total number of 
steps). The data is also displayed in a series of bars, yellow for sitting, 
green for standing and red for stepping. This information is presented 
for 15s intervals, one hour per line. The height of the stepping data 
(red) represents the stepping frequency (cadence). 
See appendix 2 for examples of output from the activPAL software.       
 
1.6.5 Validation of Activity Monitors 
 
Previously the question has been asked, whether or not the subjective 
quantifiable data that is recorded by activity monitors reveals similar 
results to those of the existing subjective models that have been used 
to assess activity levels previous to the existence of activity monitors.      
As early as 1985 Klesges and Klesges reported in a validation study 
that the hourly readings of the Caltrac activity monitor correlated with 
observer scores using the Fargo Activity Time-Sampling Survey (FATS) 
observational system.  
In a more recent study by Finn et al (2000), the (CARS) Childrens 
Activity Rating Scale (as described earlier in section 5.1.5) was used in 
direct observation of physical activity within children. The results 
obtained by this subjective lens were compared against the more 
objective readings gained from the Actiwatch activity monitor. The 
conclusions state that, ‘the activity monitor was found to be an 
accurate means of assessing children’s activity levels (pre school age) 
with high correlation between the two measures being obtained.’ They 
found the correlation coefficients were higher in those children who 
were more active, probably due to the larger ranges in the CARS 
scores. The activity monitor therefore appears to provide accurate 
information that is easily interpreted and provides information that is 
comparable to more subjective studies. The quantitative data obtained 
agrees with the qualitative data within this particular research. The 
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activity monitor would be favored due to its low long term costs, and 
increased accuracy over longer periods of time.     
The results indicate that the motion sensor counts determined by the 
Actiwatch are correlated with direct observation of activity as assessed 
by the CARS. It was concluded that these results would favor the use 
of the Actiwatch in the assessment of activity in preschool-aged 
children because obtaining a valid observational score requires 
extensive training and personnel requirements.  
Further studies that have shown activity monitors to be valid methods 
of recording activity in adults include Sanders 1980,  White et al 1992, 
van den Berg-Emons et al 2000, Walker et al 1997,   
If this result is repeatable across such studies the activity monitor will 
provide an accurate efficient means of measuring specific treatment 
outcomes and negate the necessity for time consuming methodologies 
of a subjective nature where the patient and professionals record 
activity within diaries or by other means.       
 
1.6.6 Outcome Measurement Studies Employing Activity Monitors. 
 
Community physical activity levels in disabled and non disabled 
children were measured with the SAM (step activity monitor) by 
McDonald et al (2000). Participants included 20 boys with Duchenne 
muscular dystrophy, 10 children with cerebral palsy, 10 children with 
spina bifida and a controlled convenience sample of 75 able bodied 
children. The SAM was worn on right ankle for 3 days. 
Quantitative daily physical activity profiles of, low activity level (LAL), 
medium activity level (MAL) and high activity level (HAL) were 
categorized. Where; 
LAL= low activity levels                (steps per min. = 1-15) intermittent 
steps/daily living 
MAL = moderate activity levels.     (Steps per min. = 16 -30) 
slow/walking moderate activity 
HAL = high activity levels.              (Steps per minute > 30) 
continuous walking/ running. 
 
The conclusions were made that children with physical disabilities 
spent considerably less time HAL. The measurements provide 
quantitative data profiles that represent functional output levels for 
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both disabled and non disabled children. It was stated that, the above 
categories represent new functional outcome measures for disabled 
and non-disabled children. These outcomes can be used as a measure 
for children undergoing surgery, orthotic or any other treatment.  
 
 
1.6.7 Previous Studies Employing Activity Monitors to Analyse 
Childrens Activity Levels.   
 
One study that falls into this category has been described earlier in 
section 6.4.2 above McDonald et al (2000).  
Klesges and Klesges (1987) validated a single-plane accelerometer, 
the Caltrac personal activity computer against the Fargo Activity Time 
Sampling Survey (FATS). Within this study they also investigated 
sources of error in the activity monitor. They found that the 
correlations were higher for females and overweight children were 
higher than males and normal weight children, respectively. They state 
that using this accelerometer to assess physical activity of young 
children may be ill-advised. They state that future investigations where 
a large sample is not possible should ensure the sample is sufficiently 
homogeneous to reduce potential variability that may reduce the 
correlations between the assessment methods and the criterion under 
investigation. This is the case within the research sample chosen for 
my study, the sample being reduced to type 2 hemiplegic gait 
patterns.            
 
1.6.8 Previous Studies Using activPAL  
 
A previous study, the GAPS (Glasgow Augmented Physiotherapy after 
Stroke) Study used the activPAL activity monitor to investigate 
outcomes after stroke.  
 
The activPAL has been used to inform upon materials used within 
design of hip replacements. A private company DTX Materials 
Technology researched outcomes after hip-replacement. Thirteen hip-
replacement patients and eight non-impaired subjects were monitored 
over one day.  
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Unpublished research has occurred at Salford University 
Mickelborough et al (2004) that has looked at whether or not the 
activPAL activity monitor is a valid and reliable tool to use at differing 
walking speeds in normal gait patterns. The first study analysed the 
accuracy of the monitor to count the number of steps over different 
speeds. Early indications from the data obtained within this pilot study 
indicate that for speeds between 0.3 and 1.2 metres per second the 
monitor is valid. However at speeds of 0.2 metres per second the 
monitor has a tendency to over count the number of steps, in some 
instances to a considerable degree. An activity monitor was worn on 
both legs to give an indicator towards the reliability of the device. It 
was shown that there was no significant difference between the 
monitors – p < o.6 at a confidence interval of 95% (-1.545 and 
2.717). When the slowest trial speed of 0.2 ms sq  p<0.8 (95% 
confidence intervals -0.706 and 0.862).  
The second study, analysed whether there was any difference in the 
number of step counts, dependent on which leg the monitor was 
placed. This study occurred on subjects with gait difficulties. Early 
indications from this data suggest that variations in step counts do 
occur between which leg the monitor is placed (there are no statistics 
that quantify this as yet). Suggestions for future work from these pilot 
studies state that longer/more varied structured walk should occur in 
the trials and that a greater sample size should be researched. It was 
also stated that variability in subjects will occur from day to day on 
there ability to carry out activity.   
The above findings have had implications for the protocol within this 
study. The activities carried out have been over a greater time interval 
and are more varied than the above study. The activities have also 
been set out in line with studies that have informed upon children’s 
activity patterns to simulate similar patterns of activity. The question 
of whether to apply a monitor on both legs is one of contention within 
this study. It is indicative of the hemiplegic gait pattern that the 
affected lower limb will have a differing pattern of movement to the 
contra-lateral limb. This in affect implies that the activPAL may record 
differences in step counts between the two limbs. However there may 
be some overlay effect within the gait pattern of the ‘unaffected’ limb 
resultant from the CP. There will also be compensatory movements 
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that occur in the unaffected limb again causing subtle changes to its 
pattern of movement.              
      
1.6.9 Activity within able bodied children  
 
It is important to understand the activity patterns of the able bodied 
child before measuring and commenting on the activity levels of 
disabled children. “Central to the understanding of accurate 
assessment of any population is a clear understanding of the nature of 
the individual or individuals being studied,” Welk et al (2000).  
There are reviews that have assessed different approaches of physical 
activity measurements for children including Baranowski et al (1992) 
and Eston and Ingledew (1997). The area of activity monitoring of 
children has specific challenges due to the unique way in which 
children’s activity patterns vary from those of adults. This is apparent 
to an even greater degree for the youngest of children.  One reason 
for this difference in activity patterns, may be a childs need to hone 
their central nervous system with stimulation gained through activity 
Rowland (1998). Bailey et al (1995) gives a clear insight into the 
nature of a childs activity, typically children exhibit short intermittent 
bouts of vigorous physical activity with frequent rest periods. The rest 
periods are generally of a longer duration however the results indicate 
that a child does not stay inactive for extended periods of time. The 
point is made that childrens patterns of activity are different and as 
such require different intervals of assessment and outcome measures 
to be used to assess their levels of activity. The above stated distinct 
differences between the nature of childrens activity and adult activity 
are of relevance to this study and must be taken into account in the 
methodology of the validation. To monitor childrens activity levels 
appropriately the tool must be able to monitor intermittent activity 
that occurs for short durations, but also must have the capacity to 
record the frequency and length of the rest periods. The tool must 
have the ability to record both sets of data consistently over long 
periods of time (preferably days rather than hours) to capture the true 
nature of the activity.                         
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CHAPTER 2 
 
 
METHOD          
 
2.1 Design 
 
The data collected from the activPAL activity monitor is numerical. 
Specifically, counts of the number of steps taken, the number of times 
sit to stand occurs and the time elapsed for the activities of, 
sitting/lying, standing and walking. The nature of this data and its 
presentation lends itself to a quantitative style of analysis.  
It is the priority of this methodology to establish the validity of the 
activPAL activity monitor, however trials were also undertaken to 
establish the reliability. The proviso shall also exist, that all 
instruments/scales used for measuring or comparative purposes 
against the active-pal activity monitor must themselves have been 
evaluated primarily for their validity. It is proposed that to ensure this, 
tried and tested methods of validation are employed that have been 
used successfully within previous studies, where validation of 
instruments for specific gait patterns resultant from various 
pathologies have occurred.  
 
The Protocol. 
There are two protocols to be adhered to within the research. 
Protocol 1 which details the trial for the validity of the activPAL 
monitor and Protocol 2 which details the reliability trial of the activPAL 
monitor.     
 
Protocol 1 - The Validity Trial. 
The method shall involve the direct comparison of readings taken by 
the activity monitor against observations analysed from a video 
recording taken at that time. Investigations examining the results of 
two tests are referred to as method comparison studies Ottenbacher 
(1993). Direct observation can be highly accurate and provide useful 
validation criteria for other assessment methods, specifically 
instruments for recording activity, when the problems associated with 
it are controlled Cone et al (1982). The problems that are associated 
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with direct observation are observer reliability, observer drift and 
reactivity. To reduce the possibility of experimental errors the two 
video observers shall undertake training for footstep recognition. This 
is seen as essential due to the complexities of gait patterns within CP. 
Specific guidelines will be detailed (see appendix number 5) and 
practice sessions held to try to ensure accurate foot step recognition 
as classified within this research.  Through this approach an increase 
in the intra-rater reliability of this aspect of the research protocol 
should be ensured. Correlation statistics and t-tests shall be carried 
out to test the reliability of the observations between the two 
observers.             
Children will be recruited for the study from schools within the local 
Salford and Trafford areas. Two other healthcare professionals input 
will be required to ensure that candidates within the study are graded 
accurately as being type 2 hemiplegia. The children recruited for the 
study will be asked to attend The Centre for Rehabilitation and Human 
Performance Research. They will attend with their parent/guardian 
and/or physiotherapist. The total time of attendance at the university 
will be approximately one hour, of which 25 minutes shall be spent 
with familiarization of the activities to be carried out, attaching the 
activity monitor to the patient and ensuring that the equipment is set 
up correctly. The remainder of the time taken will be dedicated to 
collecting the data (see appendix number 2 for data collection 
protocol). 
 
The participant shall be asked to undertake a set activity course. This 
will involve a set period of sitting for thirty seconds (sit 1), followed by 
a sit to stand movement, and followed by a set distance of walking 
(walk 1). The participant will then sit down for a further thirty seconds 
(sit 2) before standing to walk for a second time (walk 2) followed by 
a period of standing for thirty seconds (stand 1). After standing the 
subject will sit down for thirty seconds (sit 3). The subject will then sit 
to stand and immediately walk back (walk 3) to the original chair 
he/she started from and sit down (sit 4) for a further thirty seconds. 
This will conclude the activities required of the participant during the 
trial (see diagram 1 below). It will be ensured that the distances to be 
walked are not beyond the abilities of the participants and will be no 
further than 10 meters, the distance set out in the patient criteria. 
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Diagram 1 The Activity Course. 
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The operation of a digital video recorder shall be used to store the 
activity occurring during the trials. A stop clock will be employed to 
ensure that the pre selected time intervals of sitting and standing 
occur accurately.  
The activPAL activity monitor shall be attached to the participant to 
measure and log the activities undertaken. Once the activity trial is 
completed, the data from the activPAL monitor shall be downloaded to 
a laptop.  
Two professionals will be chosen because of their expertise in gait 
observation. They will both be given the same information/training to 
enable them to know what observations they are required to record. 
They shall both be given the same recording chart to record there 
data upon (see appendix number 9). The data to be recorded shall fall 
into two categories. The timing of the events in minutes and seconds 
shall be noted, this information will be drawn from the digital video 
recorders own runtime clock displayed on the recording. Secondly the 
number of steps during walking shall be counted and recorded. The 
two observers shall be trained as to what is defined as a step for the 
purposes of this study (see appendices number five for step training 
protocol). This will ensure that they are observing the type 2 
hemiplegic pattern and identifying and recording the number of steps 
from the same theoretical basis.  As noted earlier this will increase 
observer intra-rater reliability. To decrease the risk of observer drift 
whilst observing the video data the two observers will observe the 
data whilst at the University of Salford and will be provided with a 
quiet room to minimize the possibility of any interruptions. Two 
healthcare professionals will be chosen who are specialised in 
observing pathological gait patterns, this will further help to ensure 
observer intra-rater reliability of the data collected from the video 
analysis. They will be asked to analyze the video data and record the 
activities of interest. Correlation statistics will be carried out upon the 
two sets of data obtained from the video observation and will help to 
determine the intra-rater reliability of the two observers. 
    
The observation results from the video will then be compared to the 
data that has been gained from the activPAL activity monitor. 
Correlation and t-test statistical analysis was undertaken to prove 
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whether the monitor was a valid instrument (see introduction for 
details of the null and alternative hypotheses). 
The method to be used, as described above, has been used in 
previous validation studies for activity monitoring devices (van den 
Berg-Emons et al 2000; Walker et al 1997). 
 
Protocol 2 – The Reliability Trial. 
The reliability methodology uses the same activity course. However 
one participant will be required to complete the course twice, run 1 
and run 2. The activPAL data output from run 1 was compared against 
the data from run 2. The two sets of data obtained were correlated 
against each other and t-tests undertaken to establish whether the 
activPAL monitor was reliable.  
 
(Please see appendix number 9 for the timetable of events)  
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2.2 Apparatus 
 
Hardware 
 
activPAL activity monitor 
Monitor docking station. 
Monitor ‘stickies’. 
Stop watch 
Laptop 
Digital video camera with on screen timer. 
Designated activity course area. 
 
Software. 
 
SPSS statistical software. 
activPAL data software. 
Microsoft excel  
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2.3 The Participants taking part in the trial.  
 
2.3.1 Sample Size 
 
It is standard practice now that a researcher should calculate the 
sample size and these calculations should reveal indicative estimates 
rather than unrealistically precise figures. Nomograms give sufficient 
precision. Along with this a sensitivity analysis should show the effects 
of varying the initial requirement of the study.  Where trials are small 
they should be clearly stated as hypotheses forming (1995 Fayers and 
Machin). Fowler (1993) states that the need to consider the absolute 
size of the sample rather than the proportion of the population. 
 
The Population Sample Size Calculation. 
 
The number of participants was decided upon by carrying out 
correlation coefficient power calculations. 
A confidence interval of 95% around the mean of the primary 
outcome measure was used. 
A power of 0.8 was used within the calculation.  
A correlation coefficient under the Null Hypothesis of 0.2 was used and 
a correlation coefficient under the alternative hypothesis of 0.8 was 
used. 
 
Using the above power calculation it was revealed that a sample size 
of 12 would satisfy a power of 0.8. 
Sensitivity Analysis 
Varying the sample size to 8 (if the population size stated could not be 
acquired) would lower the power of the study to 0.6 
However if a sample size of 20 were to be obtained this would 
maximize the power to a value of 0.976  
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2.3.2 The type of cerebral palsy to be studied within the validation. 
 
Many research protocols within the area of CP fail to categorize or fail 
to state clearly the population that is being studied. Due to the 
complexity of presentations within CP this can make such studies 
difficult to interpret and sometimes render them meaningless.  
In research by R. Boyd in 1999 studying children with CP, energy 
expenditure was found to be higher in those with diplegia than in 
those with hemiplegia. They also found relatively high oxygen cost 
values within the hemiplegic group studied, due to the large numbers 
of Winters and Gage type 4 hemiplegic subjects within this population 
studied. Children with Winters and Gage type 1 and 2 hemiplegia, 
have only mildly elevated or normal values of mean oxygen cost, it 
was stated. Various papers discussed within the literature review 
substantiate that spatial and temporal parameters within hemiplegic 
gait may vary significantly from one another (Gage 1991, Rodda 2001, 
Walker 1997, Winters 1987,Wall 1987). 
The changes in energy consumptions in type 4 compared to type 1 
and 2 hemiplegia belie the discrepancies in gait patterns between the 
four classifications. Strict criteria were therefore set for the population 
that was studied to ensure that the accuracy of the research would 
not be compromised by looking at a population whose gait 
characteristics were dissimilar. For clarity it was therefore decided to 
study a particular level of hemiplegia according to Winter and Gage 
(1987) classification scale. It was decided to focus upon type 2 
hemiplegic patterns to ensure that the resultant research output was 
valid for a particular gait classification. 
It is accepted that this will result in a limitation of the usage of the 
activPAL to type 2 hemiplegic gait in cerebral palsy, this is however 
necessary to ensure the validity of the trial. However Type 2 
hemiplegia is by far the most common type in clinical practice (Rodda 
et al 2001), so the tool would provide coverage for the most common 
presentation. Children with spastic hemiplegia will usually be in levels 
one or two of the GMFCS.               
The activPAL activity monitor will have to be validated separately for 
each of the other types of gait patterns within future studies.  
The population age to be studied. 
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The age of the population to be studied within the validation of the 
activity monitor is seen as highly relevant. If a positive validation of 
activPAL is gained it is proposed that it first be used to assess the 
activity levels within the age range of 7 to 16 yrs old. This is seen to 
be the age group where the multiprofessional team is most active in 
its clinical management and it is therefore most relevant the activPAL 
is validated for the type of gait patterns associated at this age. This is 
important even though the subset of hemiplegic gait has been decided 
upon, as the clinical effects of CP are progressive and it is therefore 
paramount that the tool is valid and sensitive to the type of hemiplegic 
gait patterns present within this age group.   
 
The Inclusion Criteria for the Sample 
 
1. Cerebral Palsy resulting in hemiplegia. 
2. Hemiplegia type: Gage Type 2. 
3. Gross Motor Function Classification Scale (GMFCS) levels 1 and 2.  
4. Aged between 7 and 16 years old. 
5. Ability to walk a distance of 10m - The usage of walking aids is       
permissible. 
6. Sufficient cognitive ability to allow the subject to follow instruction 
of what activities are required. 
 
The above inclusion criteria were arrived at to represent the 
population it is believed will benefit the most from the validation of the 
activity monitor. The management of cerebral palsy is at its most 
cohesive whilst the person is still attending school. This is due to the 
input of a multidisciplinary team at this point. The interventions that 
occur at this time will have long term implications for the patient. It is 
therefore imperative, that clinicians and researchers have an effective 
means of measuring outcomes of treatment plans at this stage. 
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2.4 Procedure 
 
2.4.1 Ethical Procedures. 
 
An information sheet will be provided to the parents of the children 
participating in the trial. This shall detail what will be required of 
themselves and their child during the trial (Please see appendix 
number 7).   
The inconvenience associated with partaking in the trial is low, as 
stated above only one visit is required to Salford University. The 
potential risks associated with the study are minimal and the long term 
potential benefits, to the cerebral palsy patient group are substantial, 
if the activity monitor proves to be a valied tool. Feedback as to the 
outcome of the validation shall be sent to the participants of the study. 
Great care has been taken to ensure that all ethical considerations 
have been met. The research protocol was first verified by the 
University of Salford Ethics Committee and once ratified passed 
through the strict procedures of the Central Office Ethics Committee 
(COREC). After submission of the digital COREC form official 
confirmation was to be verified through Oldham Local Research Ethics 
Committee. I attended a meeting at Oldham ethics committee where 
clarification was sought on various issues and procedures within the 
trial. Minor alterations to the parent/guardian and children’s 
information sheets were required. The committee also insisted that a 
reply slip was placed in the initial correspondence with potential 
subjects. This reply slip had to be signed and returned to the research 
centre before any direct verbal communications occurred between the 
researcher and the subjects for the trial. These amendments were 
made and a positive decision was taken by Oldham Local Ethics 
Committee for the research to proceed. 
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2.4.2 Procedure for the Recruitment of Participants. 
 
Initial contact for the recruitment of individuals shall be through a 
physiotherapist who practices within schools in the local Salford area.  
The physiotherapist shall receive a, “Subject Identification Sheet” that 
outlines the purpose of the study and lists inclusion criteria for 
suitability within the study. After the physiotherapist identifies 
potential candidates a letter of invitation upon the study will be sent. 
Along with the letter of invitation, an information sheet will be 
attached detailing the auspice of the study. Within this, the 
information sheet will detail exactly what will be undertaken during the 
trial and what length of time is required to complete the trial. It will 
also explain any possible risks of taking part in the trial and any 
potential benefits of the trial. It will be made clear in the letter, that 
the parents may withdraw their child, at any time from the study. 
There will be a reply slip attached to the letter of invitation which the 
parents must sign and return to the researcher before direct 
communication can occur. Only after this point can a telephone call be 
made to the parents of the child to arrange an appointment. 
Confidentiality of any correspondence shall remain at all times. Any 
correspondence shall be kept separate from other documentation and 
it will be ensured that only those  party to the research have access to 
any such information.   
 
 
 
Please see appendix number 7 for the documentation listed below; 
Subject Identification Sheet. 
Information Sheet for Participant Advice. 
Letter of Invitation to Take Part in the Study. 
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2.4.3 Procedures for the observers. 
 
The definition of a step 
It was also apparent from the literature, that guidance upon the 
definition of a step was required for the professionals observing the 
video data within this study. The stride in conventional gait pattern is 
described as the distance between two consecutive points of contact 
of the same foot. The stride is made up of two steps, defined as the 
distance that the left foot is placed in front of the right foot, using the 
same anatomical point of contact. Contact usually occurring with the 
most proximal part of the heel.  
Within hemiplegic gait patterns, classified within Gage types 1 and 2 
heel contact may not be the first point of contact with the ground. 
Often the forefoot is placed on the ground first, followed by the 
rearfoot. In some hemiplegic gait patterns the heel may never come 
into contact with the ground, for instance where a limited degree of 
ankle extension exists. Due to this deviation from the norm, the 
definition of a step for the purposes of this study was defined as 
follows. The point of initial contact of the foot where mass is 
transferred to the next consecutive point of contact of that foot where 
mass is transferred (the consecutive point of contact of the foot does 
not necessarily have to be the same part of the foot). 
The following clarification was also provided to the observers. If the 
hemiplegic gait pattern resulted in a drop foot, so that during swing 
phase the foot scuffed the ground, this would not be regarded as the 
next consecutive point of contact as mass is not being transferred at 
this point.            
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CHAPTER 3 
 
 
RESULTS. 
 
The raw data tables can be seen in appendix 8 
8.1 The intra-rater data tables for the observers 
8.2 The reliability data tables from the activPAL and the observer. 
8.3 The validity data tables from the activPAL and observers. 
 
The results output from the activPAL software is generated in an excel 
spreadsheet output which can be seen in appendix number  
8.1 The reliability output. 
8.2 The validity output. 
  
It was from the excel sheet 8.2 that the activPAL data was drawn to 
be correlated against the observer outputs within the validity aspect of 
the trial.    
 
The statistical analysis was performed using SPSS statistics software, 
the outputs of which can be seen in their totality in appendix number 
13. 
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 3.1 The intra rater results for the observer 1 and observer 2. 
 
The data from the observers was used for comparative purposes 
against the data obtained from the activPAL monitor. It was therefore 
important to ensure that the observer data was reliable. 
To evaluate the reliability of the observers data Pearson correlation 
and t-tests were carried out, the results of which can be seen below.     
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8.1.1 Correlation and t-test for the sit timings. 
 
 Paired Samples Statistics 
 
  Mean N Std. Deviation 
Std. Error 
Mean 
S 30.87 15 1.407 .363 Pair 1 
M 31.33 15 .900 .232 
 
 Paired Samples Test 
 
Paired Differences 
95% Confidence 
Interval of the 
Difference 
  Mean 
Std. 
Deviation 
Std. 
Error 
Mean Lower Upper t df 
Sig. (2-
tailed) 
Pair 1 S- M -.467 .743 .192 -.878 -.055 -2.432 14 .029 
 
 
 
Correlation results; 
Pearson correlation (0.844) was statistically significant at the 0.01 
level. 
 
T – test results; 
Mean = -0.467 
Standard error from the mean = 0.192 
t = -2.432 
df = 14 
Significance (2 - tailed) = 0.029 
 
t(14)=-2.43, p<0.029 
 
From the t-test it can be concluded that the mean time recorded by 
the observer ‘S’ (30.87) was significantly different from the mean 
recorded by the observer ‘M’ (31.33). 
The reliability of the two observer’s data in respect of the sit timings 
recorded is therefore questionable. Any conclusions within the validity 
section in respect of the sit timings will also be inconclusive as a result 
of this. The reliability conclusions will not be affected as they were not 
compared to the observer data set analysed above.    
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8.1.2 Correlation and t-test results for the stand timings. 
 
 
 Paired Samples Statistics 
 
  Mean N Std. Deviation 
Std. Error 
Mean 
S 30.60 5 1.140 .510 Pair 1 
M 32.00 5 3.391 1.517 
 
 Paired Samples Test 
 
Paired Differences 
95% 
Confidence 
Interval of the 
Difference 
  Mean 
Std. 
Deviatio
n 
Std. 
Error 
Mean Lower Upper t df 
Sig. (2-
tailed) 
Pair 
1 
S - M -1.400 2.608 1.166 -4.638 1.838 -1.200 4 .296 
 
 
Correlation results; 
Pearson correlation (0.776) was not statistically significant at the 0.01 
level. 
 
T – test results; 
Mean = -1.400 
Standard error from the mean = 1.166 
t = -1.200 
df = 4 
Significance (2 - tailed) = 0.296 
 
t(4)= -1.4, p<0.296 
From the t-test it can be concluded that the mean time recorded by 
the observer S (30.60) is not significantly different from the mean 
recorded by the observer M (32.00). 
The observations made by observer S and observer M in respect of the 
number of the stand timings can be taken to be reliable.   
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8.1.3 Correlation and t-test for walk timings 
Correlations 
 
T-Test 
 
 Paired Samples Statistics 
 
  Mean N Std. Deviation 
Std. Error 
Mean 
S 28.93 15 4.758 1.228 Pair 1 
M 28.47 15 4.454 1.150 
 Paired Samples Test 
 
Paired Differences 
95% Confidence 
Interval of the 
Difference 
  Mean 
Std. 
Deviatio
n 
Std. 
Error 
Mean Lower Upper t df 
Sig. (2-
tailed) 
Pair 1 S - M .467 1.457 .376 -.340 1.274 1.240 14 .235 
 
 
 
Correlation results; 
Pearson correlation (0.952) was statistically significant at the 0.01 
level. 
T – test results; 
Mean = 0.467 
Standard error from the mean = 0.376 
t = 1.240 
df = 14 
Significance (2 - tailed) = 0.235 
 
t(14)= 1.24, p<0.235 
 
From the t-test it can be concluded that the mean time recorded by 
observer S (28.93) is not significantly different from the mean 
recorded by the activPAL (28.47). 
The observations made by observer S and observer M in respect of the 
number of the walk timings can be taken to be reliable.   
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8.1.4 Correlation and results for the number of steps taken. 
Paired Samples Statistics
26.93 15 5.837 1.507
27.20 15 5.685 1.468
S
M
Pair
1
Mean N Std. Deviation
Std. Error
Mean
 
 
Paired Samples Test
-.267 .594 .153 -.595 .062 -1.740 14 .104S - MPair 1
Mean
Std.
Deviation
Std. Error
Mean Lower Upper
95% Confidence
Interval of the
Difference
Paired Differences
t df
Sig.
(2-tailed)
 
Correlation results; 
Pearson correlation (0.955) was statistically significant at the 0.01 
level. 
T – test results; 
Mean = -0.267 
Standard error from the mean = 0.153 
t = -1.740 
df = 14 
Significance (2 - tailed) = 0.104 
 
t(14)= -1.74, p< 0.104  
 
From the t-test it can be concluded that the mean time recorded by 
the observer ‘S’ (26.93) is not significantly different from the mean 
recorded by the observer ‘M’ (27.20). 
 
The observations made by observer S and observer M in respect of the 
number of steps taken can be taken to be reliable.      
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8.1.5 Correlations and t-test for total observation data observer ‘S’ and 
observer ‘M’  
     
Paired Samples Statistics
30.04 28 3.616 .683
30.21 28 3.775 .713
S
M
Pair
1
Mean N Std. Deviation
Std. Error
Mean
 
 
Paired Samples Test
-.179 1.701 .321 -.838 .481 -.556 27 .583S - MPair 1
Mean
Std.
Deviation
Std.
Error
Mean Lower Upper
95% Confidence
Interval of the
Difference
Paired Differences
t df
Sig.
(2-tailed)
 
 
Pearson’s correlation (0.895) was statistically significant at the 0.01 
level. 
 
T – test results; 
Mean = -0.179 
Standard error from the mean = 0.321 
t = -0.556 
df = 27 
Significance (2 - tailed) = 0.583 
 
t(27)= -0.56, p<0.583 
 
From the t-test it can be concluded that the mean time recorded by 
the observer ‘S’ (30.04) is not significantly different from the mean 
recorded by the observer ‘M’ (30.21). 
 
When the observations were statistically analysed in there totality, it 
could be concluded that there is good agreement between the two 
observers. However poor agreement was revealed for the sit time data 
when anaylsed on its own.            
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Comments upon the intra rater data. 
The t-test showed that there was no significant difference between the 
two observer’s data at the 0.05 level, for the walk timings, the stand 
timings and the number of steps taken.  
However the t-test showed that there was a significant difference at 
the 0.05 level between the observers recorded data for the sit timings. 
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8.2 The Reliability of the activPAL monitor. 
 
One participant (who was not one of the five included in the validity 
trial) was asked to repeat the activity course seven times. Readings 
were taken on all seven runs and then statistical analysis applied as 
described within the methodology. Pearson correlation and t–tests 
were performed and the output is shown below.        
 
 
The SPSS output can be seen in their entirety in appendix number 9.2 
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The Reliability of the activPAL to count the Number of Steps. 
 
  
 Paired Samples Statistics 
 
  Mean N Std. Deviation 
Std. Error 
Mean 
run1 23.67 3 3.786 2.186Pair 1 
run2 24.00 3 4.359 2.517
 
  
 Paired Samples Test 
 
Paired Differences 
95% Confidence 
Interval of the 
Difference 
  Mean 
Std. 
Deviation 
Std. 
Error 
Mean Lower Upper t df 
Sig. (2-
tailed) 
Pair 1 run1 - 
run2 -.333 .577 .333 -1.768 1.101 -1.000 2 .423
 
Pearson’s correlation (1.00) was statistically significant at the 0.01 
level. 
T – test results; 
Mean = -0.33 
Standard error from the mean = 0.333 
t = -1.00 
df = 2   
Significance (2 - tailed) = 0.423 
t(2)=-1.00, p<0.423 
 
There was high correlation between the recordings of the number of 
steps by the activPAL monitor as determined by Pearsons correlation. 
From the t-test it can be concluded that the mean number of steps 
recorded by the activPAL (23.67) on run1 is not significantly different 
from the mean recorded by the activPAL (24.00) on run 2.  
 
The activPAL was deemed to be a reliable instrument for the 
measurement of the number of steps taken. 
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The Reliability of the activPAL to time the Activities. 
 
 Paired Samples Statistics 
 
  Mean N Std. Deviation 
Std. Error 
Mean 
run1 28.83 6 2.927 1.195Pair 1 
run2 28.67 6 3.204 1.308
 
 Paired Samples Test 
 
Paired Differences 
95% Confidence 
Interval of the 
Difference 
  Mean 
Std. 
Deviation
Std. Error 
Mean Lower Upper t df 
Sig. (2-
tailed) 
Pair 1 run1 - 
run2 .167 .753 .307 -.623 .957 .542 5 .611
 
 
Pearson’s correlation (0.974) was statistically significant at the 0.01 
level. 
T – test results; 
Mean = -0.167 
Standard error from the mean = 0.307 
t = 0.542 
df = 5   
Significance (2 - tailed) = 0.611 
t(2)=-1.00, p<0.423 
 
There was high correlation between the timing recordings as 
determined by Pearsons correlation.  
From the t-test it can be concluded that the mean timing recorded by 
the activPAL (28.83) on run1 is not significantly different from the 
mean recorded by the activPAL (28.67) on run 2.  
The activPAL was deemed to be a reliable instrument for the 
measurement of time spent sitting, standing and walking.  
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Comments upon the reliability of the activPAL monitor. 
 
There was a high degree of correlation between the data obtained 
from the activPAL for the timings of the activities and the number of 
steps taken which was confirmed by Pearsons correlation.   
 
The t-test showed that there was no significant difference between the 
data obtained from the activPAL monitor at the 0.05 level for the 
stand timings, the sit timings and the walk timings collectively and the 
number of steps taken.    
 
The activPAL activity monitor is therefore found to be reliable at timing 
the activities and counting the number of steps.   
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The Validity results for the activPAL monitor 
 
The statistical results for the step data shall be shown for clarity. The 
remainder of the statistical output can be seen in the appendices.  
 
 
 
8.3.1 Correlation and t-test for the sit timings.  
 
8.3.2 Correlation and t-test results for the stand timings. 
 
8.3.3 Correlation and t-test for the walk timings.  
 
8.3.4 Correlation and results for the number of steps taken.  
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8.3.1 Correlation and t-test for the sit timings.  
 
 Paired Samples Statistics 
 
  Mean N Std. Deviation 
Std. Error 
Mean 
activPAL 34.20 10 9.247 2.924 Pair 1 
observer 34.00 10 8.869 2.805 
 
 
 Paired Samples Test 
 
  Paired Differences t df 
Sig. (2-
tailed) 
  Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference       
        Lower Upper       
Pair 1 activPAL - 
observer .200 1.476 .467 -.856 1.256 .429 9 .678 
 
 
Pearson’s correlation (0.988) was statistically significant at the 0.01 
level. 
T – test results; 
Mean = 0.200 
Standard error from the mean = 0.467 
t = 0.429 
df = 9 
Significance (2 - tailed) = 0.678 
 
t(9)=0.429, p<0.678 
 
From the t-test it can be concluded that the mean time recorded by 
the activPAL (34.20) is not significantly different from the mean 
recorded by the observer ‘M’ (34.00). 
 
The activPAL was deemed to be a valid instrument for the 
measurement of time spent sitting. However this is questionable to 
some degree as low intra-rater agreement occurred between the 
observers sit timing data.      
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8.3.2 Correlation and t-test results for the stand timings. 
 
 Paired Samples Statistics 
 
  Mean N Std. Deviation 
Std. Error 
Mean 
activPAL 31.20 5 1.924 .860 Pair 1 
observer 32.00 5 3.391 1.517 
 
 
 Paired Samples Test 
 
  Paired Differences t df 
Sig. 
(2-
tailed) 
  Mean 
Std. 
Deviation 
Std. Error 
Mean 
95% 
Confidence 
Interval of the 
Difference       
        Lower Upper       
Pair 1 activPAL - 
observer -.800 4.712 2.107 -6.650 5.050 -.380 4 .723 
 
 
Pearson’s correlation (-0.537) was not statistically significant at the 
0.01 level. 
T – test results; 
Mean = -0.800 
Standard error from the mean = 2.107 
t = -0.380 
df = 4 
Significance (2 - tailed) = 0.723 
 
t(4)=-0.38, p<0.678 
 
Although the Pearson correlation proved not statistically significant,     
the t-test reveals that the mean time recorded by the activPAL (31.20) 
is not significantly different from the mean recorded by the observer 
‘M’ (32.00). 
 
The activPAL monitor was found to be a valid instrument to measure 
the time standing. 
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8.3.3 Validity Correlations and t-test for walk data.  
 
 Paired Samples Statistics 
 
  Mean N Std. Deviation 
Std. Error 
Mean 
activPAL 29.87 15 7.249 1.872 Pair 1 
observer 29.27 15 6.475 1.672 
 
Paired Samples Test
.600 3.180 .821 -1.161 2.361 .731 14 .477activPAL - observerPair 1
Mean
Std.
Deviatio
n
Std.
Error
Mea
n Lower Upper
95% Confidence
Interval of the
Difference
Paired Differences
t df
Sig.
(2-tailed)
 
 
Pearson’s correlation 0.899 was statistically significant at the 0.01 
level. 
t – test results; 
Mean = -0.600 
Standard error from the mean = 0.821 
t = 0.731 
df = 14 
Significance (2 - tailed) = 0.477 
 
t(4)=-0.73, p<0.477 
 
The t-test reveals that the mean time recorded by the activPAL 
(29.87) is not significantly different from the mean recorded by the 
observer ‘M’ (29.27). 
 
The activPAL was therefore found to be a valid instrument for the 
measurement of time spent walking. 
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8.3.4 Correlation and results for the number of steps taken. 
Paired Samples Statistics
26.40 15 6.197 1.600
27.20 15 5.685 1.468
activPAL
observer
Pair
1
Mean N Std. Deviation
Std. Error
Mean
 
Paired Samples Test
-.800 1.740 .449 -1.764 .164 -1.780 14 .097activPAL - observerPair 1
Mean
Std.
Deviation
Std.
Error
Mean Lower Upper
95% Confidence
Interval of the
Difference
Paired Differences
t df
Sig.
(2-tailed)
 
 
 
Pearson’s correlation 0.961 was statistically significant at the 0.01 
level. 
t – test results; 
Mean = -0.800 
Standard error from the mean = 0.449 
t = -1.780 
df = 14 
Significance (2 - tailed) = 0.097 
 
t(14)=-1.780, p<0.097 
 
The t-test reveals that the mean time recorded by the activPAL 
(26.40) is not significantly different from the mean recorded by the 
observer ‘M’ (27.20). 
 
The activPAL monitor was therefore found to be valid for the 
measurement of the number of steps taken. 
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Overall Results Comments on the Validity and Reliability of the 
activPAL activity monitor.  
 
The activPAL activity monitor was found to be valid and reliable for the 
measurement of the number of steps taken, the time spent sitting, 
time spent standing and time spent walking.   
 
When the outcome reaches statistical significance the null hypotheses 
(H0) is rejected. In this instance, the possibility of correlation between 
the data obtained from the video and the activity monitor being down 
to chance would be rejected if the results prove statistically significant. 
Statistical significance was conclusively proved for all of the activities 
that the activPAL measures. The null hypothesis could therefore be 
rejected. The alternative hypotheses (H1 - that the correlation 
between the results obtained from the activity monitor and the video 
capture are of statistical significance) was accepted for all of the 
activities measured.           
 
 
Further comment upon these results can be found within the 
discussion section that follows.     
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CHAPTER 9 
 
DISCUSSION 
 
Interpretation of the Statistical Results for this Pilot Study.  
 
The activPAL activity monitor was found to be valid and reliable for the 
measurement of the number of steps taken, the time spent sitting, 
time spent standing and time spent walking.   
It has to be borne in mind that this is the result of a pilot study with a 
small sample size. A power calculation was undertaken that stated the 
number of participants required to provide a power of 0.8 was eight. 
For a power of 0.9 eighteen subjects would be required. Sample size 
directly effects the confidence we can have, in the assumption that, 
our sample is representative of the population as a whole. The central 
limit theory states that a minimum of thirty subjects are required in 
the smallest sub groupings, if parametric tests are to be employed.          
The above points must be taken into account when conclusions are 
drawn from this pilot study. It is the intention of the author to 
continue to recruit further participants and to apply the same 
hypotheses and analysis.  
 
Suitability of the actvPAL for use with children 
 
Only preliminary research has occurred to date that reports upon the 
measurement of uptime (time spent upright) in a paediatric population 
(2001 Eldridge). There are aspects of the activPAL that make it ideal 
for activity monitoring of the disabled/child. The less developed 
cognitive skills of the child results in a lesser ability to effectively use 
self report questionnaires (Welk 2000). The activPAL monitor requires 
no reliance upon the subject’s cognitive skills and as such is suitable 
for children or other subjects where cognitive ability may be affected. 
Children with lower limb disabilities will potentially have a slower 
walking speed. The number of steps is broken down by the cadence. 
Normal walking cadence is between 80 -150 steps per minute (Whittle 
2002). The results from the participants fall without these bounds. 
From the table in appendix number 10 it can be seen that the cadence 
varies between 45.4 and 58.5 steps per minute. This is well below the 
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range of normal walking speeds. Previous studies have shown activity 
monitors to be affected by low levels of cadence (Crouter 2003). 
Earlier unpublished data (Kenney L, Miclelborough J 2001) tends to 
suggest that the activPAL activity monitor is not affected to any great 
degree by reductions in the levels of cadence. The resultant reduction 
in cadence that is present in the children with type 1 hemiplegia within 
this study has been shown not be a source of error when using the 
activPAL monitor.      
Previous methods of measuring activity levels have had flaws within 
them that preclude them from measuring across the whole age range 
of children. The monitor does not exhibit any ceiling (Damiano 1996), 
or floor effect (Nordmark 2000) as exhibited by the GMFM.  The 
deployment of the activPAL monitor will result in no such 
methodological weakness in this respect. Issues arise with 
conventional activity assessments such as the CARS around the cost of 
deploying health care professionals as observers of activities (Puhl 
1990).  Lengthy and costly observation is not required from the 
healthcare professional when using the activPAL monitor to observe 
children in the community. 
 
Discussion upon aspects within the research trial  
Weaknesses within the methodology of the research. 
 
Weaknesses were identified within the study. Cone et al (1982), state 
that direct observation can be highly accurate and provide useful 
validation criteria for other assessment methods, specifically 
instruments for recording activity. However this is only when the 
problems associated with it are controlled. The problems that are 
associated with direct observation are observer reliability, observer 
drift and reactivity. The protocol took steps to reduce the possibility of 
errors due to the above. The correlation and t-tests that occurred to 
identify any discrepancies between the two observer’s data testify that 
these protocols were not entirely successful, producing good 
correlation between the two observers for the walk and stand timings 
and the number of steps taken. However, producing poor intra rater 
results in respect of the sit timings. The protocol ensured that the 
observers were trained at the same time both being given identical 
written support instructions to identify the activities from the video 
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recordings and enter the timing data within the excel calculation 
sheets. In respect of the sit timing data the definition between when 
sitting starts and finishes may not have been clearly defined leading to 
a significant intra rater error. The measures in the protocol could not 
ensure the observers accuracy in stopping the video at exactly the 
correct point and some degree of reaction time error would affect all 
the timings taken for the activity events. So some degree of error is 
inherently built into the study design from this aspect. This source of 
error has to be taken into consideration when looking at the raw data 
and the statistical data.   
 
Amendments to the trial protocol. 
 
The protocol for the trial had to be amended on two counts to avoid 
built in errors within the study. The timings of the periods of sitting 
had to be reduced from one minute to thirty seconds. This became 
evident after the first participants trial run. It was clear from this run 
that the younger participants within the trial would find it difficult to sit 
still for the full sixty second duration stated. The sitting events were 
therefore reduced to thirty seconds to reduce the likelihood of the 
younger participants getting up from the chair too early.  
An amendment to the protocol occurred relating to the data taken by 
the two observers of the video. The switching on and off of the 
monitor requires the insertion of a male six pinned switch into the 
female counterpart at the base of the monitor. This operation made it 
difficult to accurately switch on and off the monitor and made for an 
unclear start point and finish point to the trial. It was particularly 
difficult to ensure that the observers would record these points 
correctly from the video output.  It was therefore decided that for 
observation purposes the trail would start at ‘walk 1’ this being a more 
clearly identifiable point for the observers of the video. The trial would 
be terminated at the end off walk 3. The switching has been designed 
in this manner to prevent the accidental switching off of the monitor 
whilst being worn in the community. The accuracy of the time off 
switching on and off the monitor to the exact second is not an issue in 
respect of its clinical application within the community.  
 
Amendments for future trial protocols.   
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In future trial protocols it will be ensured a clear definition of what 
defines the start and the ending of the sit activities. This should 
resolve the lower intra rater affect that occurred within this specific 
part of the trial.     
In line with the above ensure that the reliability aspect of the trial 
procedure carries the same rigorous standards as the validity aspect of 
the trial. Act in accordance with all other aforesaid amendments that 
were made within the current trial procedure.  
 
 
Failure to tightly define the words and terms that we use within 
research studies can lead to serious misinterpretations of results and 
hence inappropriate treatment may result form this. It is therefore 
imperative that we define what we mean by activity and the term 
being active. For instance, in a previous study heart rate has been 
used to measure activity (Armstrong 1990) and cut off values below 
and above certain heart rate values have been used to interpret when 
that individual has been deemed to be active. Depending on the level 
of this cut off value serious variations in activity output can be drawn 
from the data. This has occurred in past studies, where heart rate 
levels relevant to adult activity have been applied to studies into 
childrens activity levels. No such methodological potential for error 
exists when using an activity monitor, making it superior to non-direct 
measurements of activity.             
 
Weaknesses within the statistical analysis. 
The outcomes of investigations such as this are dependent upon the 
statistics employed being both suitable for the nature of the study and 
their accurate interpretation. Sanchez (1999) states, “In the process of 
designing a clinical trial, the accuracy and precision of an endpoint is 
of critical importance in being able to determine valid results. In the 
creation and subsequent testing of the validity of the endpoint, it is 
desirable to show that on repeated measurements the endpoint can 
be measured precisely, and that it is reproducible with not only itself 
but with any gold standard that can assess accuracy. Short of having 
this gold standard, we rely on showing that the end point is reliable.”         
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Correlation coefficients have been used within the statistics of this 
study, however there application is questionable when undertaking a 
validity trial between two instruments. Two measures may correlate 
highly, yet there could be substantial differences in the two measures 
across their range of values (Hopkins W 2004). To reduce the 
possibility of inaccuracies in respect of this, t-tests were also carried 
out in this study, where the differences between the means of the two 
sets of data would be highlighted. 
 
Bland (1986) states that validity investigations are often analysed 
inappropriately, notably by using correlation coefficients. The use of 
correlation is misleading. An alternative approach to this study would 
have been to use a graphical technique that employs simple 
calculations. This can be interpreted together with an assessment of 
repeatability. Several researchers have argued that the Pearson r is a 
measure of linear association (co-variation) between variables and 
does not provide accurate estimates of direct agreement (Ottenbacher 
1993). Within the study several commonly used quantitative methods 
to establish agreement were compared it was demonstrated that the 
Pearson r is not appropriate for use in studies where the purpose is to 
determine whether two instruments are interchangeable. The 
procedure recommended is referred to as the limits of agreement 
method, this emphasizes the clinical comparability of two instruments 
(or raters), instead of focusing solely upon the statistical relationship. 
Agreement with the above is also stated in a paper by Indrayan A et 
al, it is also stated that intra-class correlation coefficient may be 
employed, both statistical methods having their own merits and 
demerits.  Hopkins in 2004, disagrees with the limits of agreement 
theory, in favour of using regression when comparing measures. He 
argues that the Bland-Altman plot can lead to inaccurate conclusions 
about the validity of the measure as a systematic proportional bias in 
the instrument to be validated is recorded even though none is 
present.  
Putting the statistical approaches into some context Bland and 
Altmann (1986) state, “we want to know by how much the new 
method is likely to differ from the old; if this is not enough to cause 
clinical problems in clinical interpretation we can replace the old 
method by the new or use the two interchangeably. How far apart 
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measurements can be without causing difficulties will be a question of 
judgement.” The correct statistical methodology to be employed in 
such trials is still debatable as can be seen from the above evidence. A 
means of estimating what may be an acceptable difference, for a 
given data set would provide a more scientific end point to such 
studies.  
 
The Application of the activPAL Monitor.   
 
Within this study the main aim was to provide evidence towards 
whether or not the activPAL activity monitor is a valied and reliable 
tool for the measurement of community activity in children with type 2 
hemiplegia (as classified by Winters 1987) resultant from cerebral 
palsy. In the first half of the thesis relevant literature was reviewed to 
enlighten the reader as to the current need to develop and validate 
activity measurement tools. This would enable productive research 
into current and future treatment modalities and hence the facilitation 
of evidence based practice.  To enable this, literature was cited to 
inform upon current assessment and measurement techniques, 
applied within research and clinical practice in the area of cerebral 
palsy. The past and current nature of activity monitoring was also 
considered. 
The context for the clinical application of the activity monitor is 
perhaps clearer after considering certain factors within the current 
educational system for children with disabilities. Over the past decade 
there have been changes within the educational system that have 
moved progressively towards the integration and inclusion of children, 
with both learning and physical disabilities, within mainstream schools.  
As this occurred the role of the health care professionals caring for 
these children has had to change, producing new challenges on 
improving the quality of lives of the children in their care. The 
multiprofessional team, consisting of the Orthotist and Physiotherapist, 
have found it difficult to maintain the same level of contact with the 
population they treat, as it has become increasingly dispersed 
throughout the educational system. This has meant that conventional 
routine observations that would occur within the setting of the special 
needs schools now occur with reduced frequency in the setting of 
main stream education. 
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Traditionally, within schools that are created for the sole purpose of 
educating children with special needs, the physiotherapist would be 
able to treat and hence observe the children throughout the whole of 
the week. The Orthotist could then gain feedback from the 
physiotherapist on any Orthotic intervention that may have occurred 
and hence effect future treatment actions. One result of the inclusion 
policy was a decrease in the actual contact time between the 
physiotherapist and the child, and hence a crucial feedback 
mechanism was lost. This decrease in accurate feedback may have 
lead to a reduction in the effectiveness of Orthotic intervention. 
Where careful selection procedures are in place, there are many 
advantages to be gained from children with disabilities partaking in 
mainstream education and there exists a need to facilitate inclusion at 
all levels.  The activPAL has been shown during the trials to produce 
data with minimum impact to the child. This may enable children to 
continue their education within the mainstream school environment, 
without a serious compromise to their Orthotic treatment programme. 
Thus the activPAL has real scope to be implemented as a clinical tool 
as well as a research tool, potentially reducing the negative impact 
upon the clinical needs of the child.       
Due to its ease of use the implementation of activPAL within current 
clinical and community settings could readily occur. It will create an 
increase in research opportunities for practicing clinicians, once again, 
due to its ease of use. To employ the activPAL monitor there is no 
technical knowledge relating to the electronics required. It therefore 
provides a user friendly medium which is simplistic in its nature. The 
time required to both set up a monitor on the patient and to download 
the information is minimal and could be built into the clinicians 
schedule without too much difficulty. As seen within this study the 
software produces data in excel and graphical format that enables 
easy interpretation. These factors are of major importance if such 
emerging technologies are to be successful in changing our 
procedures of practice for the better.  
Such future deployment of the activPAL may prove effective within the 
facilitation of Audit Procedures. Strategies for future treatment plans 
could then be based on objective data and the strategies once 
implemented measured by the same objective tool. This may result in 
the fine tuning of current treatment or in some cases where the 
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results proved a specific treatment to have no conclusive benefits the 
treatment procedure could be revised. If no measurable improvements 
occurred after revising the procedures then the treatment would be 
dropped from the overall treatment plan.  
The above scenario is one that does not occur within many areas of 
conservative medicine relating to CP due to the lack of measuring 
tools that are both valied and reliable and easy to  employ. Accurate 
data that can be used for further interpretation is therefore scarce. 
Due to this fact evidence cannot then be pooled together from 
different centres around the world to have any bearing on future 
treatment regimes. Hence it is difficult for specific global and national 
guidelines to be formulated to guide treatment within departments at 
a more local level. 
The obvious advantage for the clinician of the activPAL activity monitor 
is that it obtains data with minimum input of time being required for 
both collection and retrieval of data. Thus in the current climate, 
where evidence of good clinical practice is becoming more and more 
important, could provide the means to achieve the required outcome 
measures. These measurements would be efficiently taken and would 
not result in clinicians having to significantly reduce their patient 
contact time undertaking core responsibilities. This would be a realistic 
method to employ within the NHS Trust hospitals and within the 
community setting where clinician time is of a premium.  
It should be noted the possibility that activity may correlate with a 
child’s developmental status or degree of disability can only be 
explored once a normative database for the measurement of activity in 
children has been established (Eldridge B et al 2003). In respect of 
this the activPAL monitor could be used to build a normative database 
for activity in the different classifications of cerebral palsy. This could 
then be used for comparative purposes after differing treatment 
regimes.        
 
 
 
The study has highlighted the need for future research into the design 
and application of activity monitors. It has highlighted that the activity 
monitor has the potential to become a useful tool producing valied and 
reliable outcome data. The robustness of the activPAL as an 
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assessment tool will only be improved as successive validation studies 
occur within the filed of cerebral palsy. Only when further validation 
studies have occurred for diplegic and mixed walking patterns could 
the device be termed robust.       
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CONCLUSION 
 
A major challenge still exists for those professionals treating disabled 
children in how to assess the effectiveness of various intervention 
programmes (Bax 1985). Many of the methods that the different 
disciplines employ appear to be effective to some degree and 
wherever possible new ways of treating patient groups are deployed in 
clinical practice. It became evident in my recent years of clinical 
practice and as evidenced within the literature search of this thesis, 
that many of these practices, although of benefit, were very rarely 
measured in terms of their outcomes. On looking further it became 
evident that many of the theories used within conservative disciplines 
were indeed just that and the need for high quality research and 
evidence to validate particular treatment regimes is required. Pearson 
(1982) states that parents and professionals invest time and costly 
resources in diverse therapy and educational endeavours, but there is 
a lack of scientific evidence about the influence of various approaches 
on outcome.  This is an increasing source of frustration for many 
HCP’s who recognise this as being the case yet find themselves 
without the time or the resources to alter the course of this historical 
situation.  The call for more refined research was made by Shonkoff 
and Hauser-Cram (1987), to identify clearly what were important 
programme components. Anyone who has worked amongst the 
plethora of treatment modalities within the area of C.P. alone will 
appreciate the magnitude of this request. Due to the long standing 
history of poor funding within this area very little research has 
occurred and the quality of existing research, or perhaps the relevancy 
of research to actual clinical practice is debatable.  
The need therefore for increased accuracy in measuring activity is 
required if activity monitoring is to be used both within research as an 
outcome measure to further evidence based practice and within the 
clinical setting to monitor on going treatment and thus help to fill the 
existing gap of knowledge within the area of CP treatment.  
 
In conclusion from the results of this trial the activPAL activity monitor 
has many of the attributes that are required from a tool specifically 
required to measure activity within the community. The data gained 
within this pilot study gave an early indication as to the accuracy of 
 59
the monitor.  It has to be borne in mind that this is the result of a pilot 
study with a small sample size and further trials are required with a 
larger population before any of the above conclusions are verified. To 
substantiate this beyond any doubt the author intends to recruit 
further participants to increase the size of the population. Further 
statistical analysis may then occur.  
Following this, further research will verify whether the activPAL 
monitor is a suitable instrument for other classifications of CP and 
gross motor classification. Liaison with activity monitor companies will 
occur as required to highlight findings that may be relevant to future 
design specifications. 
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APPENDIX 
 
Appendix 1 
 
Current Commercially Available Activity Monitors. 
During the literature search the monitors below were found to be the 
most frequently used. 
 
The StepWatch Activity Monitor (SAM) 
 
This is a highly adjustable, computer programmable instrument that is 
worn on the ankle and records the number of steps taken every 
minute for up to 2 months between downloads. It is unobtrusive, 
waterproof, maintenance free and extremely durable. Accuracy 
typically exceeds 98% regardless of walking style, from completely 
functional to highly impaired. (Cyma 2004) 
 
The Actiwatch® (registered trademark of Mini Mitter Company, Inc., 
Sunriver) 
 
The Actiwatch is a long-term activity monitoring device that can be 
worn on the limb(s) or the torso without discomfort. The compact size 
(27 mm X 26 mm x 9 mm) of the device is suitable for use in children, 
although it has not been validated for assessing physical activity in 
preschool-aged children. Actiwatch activity monitor. The Actiwatch 
activity monitor contains an omni-directional sensor capable of 
detecting acceleration in two planes. Sensitive to 0.Olgravity (0.098 
ms this type of sensor integrates the degree and speed of motion and 
produces an electrical current that varies in magnitude. An increased 
degree of speed and motion produces an increase in voltage. The 
monitor stores this information as activity counts. The maximum 
sampling frequency is 32 Hz. The device has been used in sleep 
studies and is beginning to be used in energy expenditure studies.  
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A recent comparison of activity monitors worn during treadmill walking 
has provided strong correlations with energy expenditure. This method 
is useful for validating motion sensors for adult activities; however, it 
may be inappropriate for validating sensor counts in children due to 
the intermittent nature of the child’s activity patterns. Simultaneous 
observational data are needed to compare with the Actiwatch activity 
counts to evaluate it as a useful instrument of physical activity for 
preschool aged children.  
 
 
The NUMACT ambulatory monitor.  
This activity monitor was developed at Freeman Hospital, Newcastle 
upon Tyne. The NUMACT enables the logging of an individuals activity 
for a period of twenty four hours. Activity is recorded as time spent 
sitting, standing and lying down. During walking the number of steps 
and their timing is recorded. The weakness of this particular activity 
monitor is its relatively small amount of on-board memory which only 
allows the recording of data for one day. 
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Appendix 2 Example of graphical data output from activPAL. 
 
                          (activPAL information brochure 2005) 
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                          (activPAL information brochure 2005) 
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                          (activPAL information brochure 2005) 
 
 
                          (activPAL information brochure 2005) 
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Appendix 3 Data Collection Protocol for activPAL. 
 
Procedure for the collection of data. 
1 First make sure that any old data has been purged from the memory 
card of the activPAL monitor. 
 
2 Affix the monitor to the subject’s thigh using ‘stickies provided’ or 
similar, ensuring the device is the correct way up (guided by 
picture of man on monitor, see picture below). 
 
3 Using the tool provided, switch on the monitor. 
   At the same time start the video recorder.  
 
4 Start the sequence of activities as described in the activities 
protocol. 
 
5 Switch of the monitor once the activities have been completed. 
 
6 Take the activPAL monitor off the subject’s leg. 
 
The device will record up to 110 hours with a maximum of eight 
sessions in the recording period. NB THIS WILL MEAN THAT THE 
MAXIMUM NUMBER OF SUBJECTS TO ATTEND THE TRIAL IN ANY 
ONE DAY WILL BE 8. IF MORE THAN  EIGHT SUBJECTS ATTEND IN 
ONE SESSION THE DATA WILL HAVE TO BE DOWNLOADED FROM 
THE MONITOR TO THE LAPTOP BEFORE THE NINTH SUBJECT.  
 
 
Procedure for the downloading/purging of data from the 
activPAL monitor. 
1 First switch on the laptop then start the activPAL software. 
 
2 Connect monitor download lead to a USB port on the laptop. 
 
3 Now connect the activPAL monitor to the download lead. 
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4 Start the activPAL monitor with a pin (a constant red light will be 
displayed on the monitor). 
 
 
 
5 Click settings / port/ and select the correct port that the monitor is 
connected to. 
 
6 Press connect icon (far left on the activPAL menu bar). 
 
    
    To purge the memory; 
To clear old data that may be held in the right hand box, click  
program and clear memory’, then answer ‘yes’ to the prompt. 
 
 
To download the data; 
First tick the ‘process data’ box (default). 
Click on required data file (in the box on the right hand side of 
the screen. 
Save the file into a separate folder (initials/session number/date, 
eg. MMcA2-14-03-06). 
Repeat this for all files. 
Backup the data on another hard drive. 
Purge memory once the data are saved separately. 
Disconnect the monitor. 
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Appendix 4 
 
Procedure for identification of subjects for the trial; 
 
All subjects will be assigned an identification code prior to taking part 
in the trial. This is in accordance with the procedures ratified by Bolton 
ethics committee to ensure subject anonymity. The code assigned will 
be random and consist of two numbers and two letters eg 1A7H.  
 
ALWAYS identify the subject on the video using a notice with the 
subjects identification code and the date of the trial. 
 
ALWAYS attach the activPAL to the affected leg (the side of the 
hemiparesis). 
 
ALWAYS use the same activity monitor for all of the trials. 
 
Run the video continuously form BEFORE switch on until AFTER the 
final switch off of the monitors. 
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Appendix 5 
 
The activity course procedure. 
 
Equipment Required. 
One appropriately labeled activPAL activity monitor. 
One monitor ‘switch device’ to switch the monitor on and off. 
One set of ‘stickies’ to adhere the monitor to the subject.   
One stop watch 
One digital video recorder with video time capture display switched on. 
Participant information file (with ‘agreement to participate form’ as pre 
signed by parent or guardian of the child before attendance).  
Activity course arranged as diagram below with two chairs in positions 
as marked.   
Signs to inform research centre staff that a trial is occurring and 
between which hours this will occur.  
 
There shall be two researchers required for this part of the trial. 
One will be required to video the participant around the course 
ensuring that the lower limbs and feet are visible at all times (this 
must occur to ensure that the observers can count the number of 
steps accurately). 
The second will be in charge of a stop watch to ensure the pre 
determined times of sitting and standing occur accurately. 
  
The participant shall be asked to undertake a set activity course. This 
will involve periods of sitting, standing and walking. It will be ensured 
that the walking distance is not beyond the abilities of the participants 
and will be no further than 10 meters, the distance set out in the 
patient criteria. See below; 
 
1 Start sitting in the chair ‘sit 1’ in area A (sitting for a period of thirty 
seconds). 
2 Stand and walk down the corridor  then sit down ‘sit 2’ in the chair 
for 30 seconds. 
3 Stand and walk to the top of the corridor then turn around and 
stand by the window ‘stand 1’ for 30 seconds, then sit down in the 
chair for a further thirty seconds ‘sit 3’ 
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4 Stand and walk to the chair in area A and sit down ‘sit 4’ for 30 
seconds.                 
   
Refer to the diagram below.  
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Diagram - The Activity Course. 
 
 
SIT 
1 
SIT 
2 
SIT 
3 
STAND 
1 
SIT 
4 
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WALK 1 
 
WALK 2 
 
WALK 3
Appendix 6 
 
The results file procedure. 
 
The results are stored in folder; 
D:\TaughtMRes\MResDissertation\TrialResults  
A back-up is stored on;  
H:\MResDissertation\TrialResults 
 
The data falls into two categories; 
1 The step data; 
   The step data taken from the video. 
   The step data taken from the activPAL monitor.  
 
2 The timing data; 
   The timing data taken from the video.    
   The timing data taken from the activPAL monitor. 
 
STEP DATA 
 
The data for the steps is taken from the video by the two observers  
(M=Martin, T=Steve) and the results placed in the appropriate box. 
  
The Step Data.   
This data includes; the number of steps taken after the first sit phase 
(walk 1), the number of steps taken before the first stand phase (walk 
2) and the number of steps taken before the fourth and final sit phase 
(walk 3). 
A single figure is placed into one of the appropriate three rows and 
can then be summed automatically.    
 
 
The Timing Data. 
Timings are noted by the observers from the video for the intervals; 
1 Initial sitting time (sit 1). 
2 Sit to stand – 1st walk – to beginning of sit (sit 2). 
3 Start of sit 2 until start of walk 2 
4 Walk (walk2) to the beginning of stand (stand 1) 
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5 Start of stand 1 until start of sit (sit 3).  
5 Start of sit 3 until walk (walk 3)  
6 Start of walk 3 to start of sit (sit 4). 
5 Start of sit until end of sit (sit 4) 
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Appendix Number 7.  
Guidance for observers of the video. 
 
The stride in conventional gait pattern is described as the distance 
between two consecutive points of contact of the same foot. The 
stride is made up of two steps, defined as the distance that the left 
foot is placed in front of the right foot, using the same anatomical 
point of contact. Contact usually occurring with the most proximal part 
of the heel.  
Within hemiplegic gait patterns, classified within Gage types 1 and 2 
heel contact may not be the first point of contact with the ground. 
Often the forefoot is placed on the ground first, followed by the 
rearfoot. In some hemiplegic gait patterns the heel may never come 
into contact with the ground, for instance where a limited degree of 
ankle extension exists.          
 
 
The definition of a step for this research.  
 
Due to this deviation from the norm the definition of a step for the 
purposes of this study shall be, the point of initial contact of the 
foot where mass is transferred, to the next consecutive point 
of contact of that foot where mass is transferred (the 
consecutive point of contact of the foot does not necessarily have to 
be the same part of the foot – for instance the forefoot or midfoot 
could be the point of weight transfer). 
The additional proviso applies; if the hemiplegic gait pattern resulted 
in a drop foot, so that during swing phase the foot scuffed the ground, 
this would not be regarded as the next consecutive point of contact, 
as mass is not being transferred at this point.  
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Appendix Number 8 
Order of Participants on the digital video capture. 
 
Participant 2 
Participant 3 
Participant 4 
Participant 5 
Participant 1 
 
 
Order of Events 
 
Sit 1 – walk 1 – sit 2 – walk 2 – stand 1- sit 3 – walk 3 – sit 4   
 
 
Ignore sit1 event – no need to time  
 
All other events time 
 
 
The sitting timings. 
 
Start of sit time is when the participant’s buttocks strike the seat. 
End of sit time is when the participant’s buttocks leave the seat.  
 
Sit 4 – stop the clock when the on/off pin is pulled out of the 
activPAL monitor. 
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Appendix Number 9 Correspondence/Information to the Trial Participants.  
                    
9.1 Letter of Invitation to Take Part in the Trial; 
A study to test the suitability of a device that measures activity for usage 
with people with cerbral palsy. 
 
Dear Parent/Guardians, 
 
Thank you for showing an interest, with the possibility of your child taking 
part in the above research. I have included a detailed outline of what taking 
part in this trial will involve. A brief outline is shown below. 
 
The activPAL activity monitor is a small device that attaches to the body so 
that activity levels can be measured. Your child will be required to wear 
either shorts or a skirt whilst carrying out the tasks as the monitor is required 
to be attached to your thigh. The activity that we measure will be that of 
sitting, standing and walking. The venue for the research is Salford 
University, at The Centre for Rehabilitation and Human Performance 
Research.  
 
The goal of the research is to make sure that the device measures these 
activities accurately, for people with cerebral palsy.  
 
Please remember that if at any time you wish to withdraw your child from the 
study you are at will to do so.     
 
 
I will be contacting you within the next week, so that you can ask any further 
questions that may arise. Thank you for considering your childs participation 
within this study. 
 
Yours Sincerely, 
 
Mark McAloon 
Orthotics and Prosthetics Lecturer, 
Centre for Rehabilitation and Human Performance Research 
University of Salford 
Frederick Road 
Salford 
M6 6PU   
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9.2 CONSENT FORM FOR PARTICIATION IN RESEARCH  
 
Title of Research Project. 
 A Research Study to Validate an Activity Monitor for Usage with Cerebral 
Palsy. 
 
Name of Researcher:   Mark McAloon 
 
1. I understand that my childs participation in this research is voluntary and I am free to 
withdraw him/her at any time, without giving any reason, without their medical care or 
legal rights being affected.   
 
          
      
 
2.  I confirm that I have received and understand the information sheet for the above study 
and have had the opportunity to ask questions on any terms or issues that may have been 
unclear.                  
 
 
 
 
 
3. I agree to my child being videoed as part of this study on the understanding that the 
video will be erased at the completion of this research. The video will not be used for any 
other purpose other than this research project.    
                      
 
 
 
 
4. I agree to take part in the research as titled above.  
 
 
 
 
 
Name of Parent/Guardian                   Date                   Signature   
 
Name of  researcher                             Date                   Signature 
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9.3 Information Sheet for Participant Advice. 
 
A study to test the suitability of a device that measures activity for usage with 
people with cerbral palsy. 
 
Introduction 
A device called an activity monitor measures and records various forms of actvity. One 
such device is activPAL activity monitor. This device measures the length of time that a 
person is inactive or active. It also records when a person changes there posture, for 
instance, when a person moves from sitting to standing and during walking will record the 
number of steps taken. Such information can be useful to help decide whether treatments 
that people undergo are being effective. This information would be particularly helpful in 
some treatment areas of cerebral palsy. 
 
 
Why do we need participants to take part in this trial?         
We need participants to take part in this trial to ensure the accuracy of 
the activPAL. In this way we can ensure that any future research 
undertaken with the activPAL activity monitor will be correct and result 
in improvements in the way in which we treat our patients. 
 
What participation in the trial involves. 
Your child will be required to partake in one testing session only. The 
whole process will take place in the University of Salford and will take no 
longer than 1hour. 
 
During this time the researcher will ask your child to undertake a number of activities, 
such as walking and sitting for a set amount of time. The distance your child will be 
expected to walk will be a distance within their ability. However, if at any time your child 
feels that they are unable to complete any of the tasks, they may stop. 
 
Whilst you child is undertaking the activities he/she will have an activity monitor attached 
to them. This will be attached to the thigh with tape. He/she will be required to wear shorts 
or a skirt during the trial due to this fact.    
 
Your child will also be videotaped whilst carrying out the set tasks. The video will be used 
to show that the activPAL is recording your movements accurately. At the end of the 
research study the video recording will be erased. The time for your child to complete this 
part of the study will be approximately 20 minutes.            
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Are there any possible risks in taking part in the study? 
There are no risks in taking part in the study as the activPAL activity 
monitor is a safe and approved battery-operated device. At all times 
during the activities there will be a researcher next to you to assist as 
necessary. 
 
Are there any benefits of taking part in the study? 
There are no immediate benefits to your child partaking within this 
study. However, if the activPAL proves to be successful, as a tool to 
monitor activity in people with cerebral palsy, you will be notified.  
 
What will happen now? 
I will contact you in the next few days to organise when would be a 
suitable time for you and your child to partake in the trial. If you would 
like to talk to me before then, please contact me on the telephone number 
below.  
 
Remember, taking part in this trial is voluntary and if at any time you 
wish to withdraw your child from the trial, for whatever reason, it will 
not be a problem.         
 
  
 
 
 
Mr Mark McAloon (Lecturer at the University of Salford/ Post Grad Research 
Student); Telephone Number: 0161 2952270 
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Appendix number 10  Section of the observer excel spreadsheet data 
form.  
                          
THE VIDEO 
DATA 
       
        
A) The timing 
data 
       
        
Subject 1        
        
  time(secs)  time(secs)  time(secs)   
 sit 1  walk 1  stand1   
 sit 2  walk 2     
   walk 3     
Total  0  0  0  
        
        
Subject 2        
        
  time(secs)  time(secs)  time(secs)   
 sit 1  walk 1  stand1   
 sit 2  walk 2     
   walk 3     
Total  0  0  0  
        
 
                          
B) The Step Count Data.    
    
Subject 1    
    
  Number of steps  
 walk 1   
 walk 2   
 walk 3   
Total  0  
    
    
Subject 2    
    
  Number of steps.  
 walk 1   
 walk 2   
 walk 3   
Total  0  
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Appendix number 11 
 
Timetable of stages within the research. 
 
7TH December Obtain Ethical Approval. 
9th January Complete and write up the literature search. 
9th January-27th February Completion of the trials. 
27th February-17th April Analysis and presentation of the data. 
17th April-26th May Discussion and conclusion write up. 
Appendix Number 9 The activPAL excel spreadsheet data.  
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12.1 The reliability spreadsheets  
12.1.1 Activity run 1 
Activity profile for Euan run 3 324DG404 03Apr06 01-44-45 PM - 03Apr06 01-48-09 PM - 
Day 1 
 
activPAL Serial Number: 324DG404       
Start Time: 01:44 PM  03-
Apr-06 
       
Stop Time: 01:48 PM 03-
Apr-06 
       
Elapse
d Time:  
00:03         
Date Hour Sit/Lie 
(min) 
Stand 
(min) 
Step 
(min) 
sit/stand 
movements 
stand/sit 
movements 
No 
steps 
EE 
(MET.h) 
03-Apr-
06 
1:00 
PM 
1.3 0.7 1.2 2 2 124 0.117  
          
15s data for Activity profile for Euan run 3 324DG404 03Apr06 01-44-45 PM - 03Apr06 01-48-
09 PM - Day 1 
activPAL Serial Number: 324DG404       
Start Time: 01:44 PM  03-
Apr-06 
       
Stop Time: 01:48 PM 03-
Apr-06 
       
Elapsed 
Time:  
00:03         
          
Time Sittin
g (s) 
Standin
g (s) 
Steppin
g (s) 
Steps Energy Expenditure (MET.h)   
13:44:45 0 0.2 14.8 14 0.0106     
13:45:00 1.5 1.5 12 22 0.014     
13:45:15 15 0 0 0 0.0052     
13:45:30 13.9 1.1 0 0 0.0053     
13:45:45 0 1.1 13.9 26 0.0151     
13:46:00 0 9.2 5.8 10 0.0095     
13:46:15 0 15 0 0 0.0058     
13:46:30 6.5 8.5 0 0 0.0056     
13:46:45 15 0 0 0 0.0052     
13:47:00 7.5 1.9 5.6 12 0.0093     
13:47:15 0 0 15 28 0.0161     
13:47:30 5.4 2.2 7.4 12 0.0103     
13:47:45 15 0 0 0 0.0052     
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12.1.2 Activity run 2 
Activity profile for 324DG404 Euan run 4  03Apr06 01-49-10 PM - 03Apr06 01-52-32 PM - Day 1  
activPAL Serial Number: 324DG404       
Start Time: 01:49 PM  03-Apr-
06 
       
Stop Time: 01:52 PM 03-Apr-
06 
       
Elapsed 
Time:  
00:03         
Date Hour Sit/Lie 
(min) 
Stand 
(min) 
Step 
(min) 
sit/stand 
movements 
stand/sit 
movements 
No 
steps 
EE 
(MET.h) 
03-Apr-
06 
1:00 PM 1.4 0.7 1.2 2 2 122 0.118  
          
15s data for Activity profile for 324DG404 Euan run 4  03Apr06 01-49-10 PM - 03Apr06 01-52-32 PM - 
Day 1 
activPAL Serial Number: 324DG404       
Start Time: 01:49 PM  03-Apr-
06 
       
Stop Time: 01:52 PM 03-Apr-
06 
       
Elapsed 
Time:  
00:03         
          
Time Sitting 
(s) 
Standing 
(s) 
Stepping 
(s) 
Steps Energy Expenditure (MET.h)   
13:49:15 0 0 15 24 0.0143     
13:49:30 8.7 2.2 4.1 6 0.0082     
13:49:45 15 0 0 0 0.0052     
13:50:00 6.7 1.9 6.4 14 0.01     
13:50:15 0 1.9 13.1 22 0.0144     
13:50:30 0 15 0 0 0.0058     
13:50:45 0 15 0 0 0.0058     
13:51:00 14.6 0.4 0 0 0.0052     
13:51:15 15 0 0 0 0.0052     
13:51:30 0.9 1.9 12.2 24 0.0141     
13:51:45 0 0 15 28 0.0157     
13:52:00 11 1.9 2.1 2 0.0067     
13:52:15 15 0 0 0 0.0052     
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12.2 The validity output from the activPAL monitor in excel format.   
 
12.2.1 Participant no.1  
Activity profile for 324DG404 25Apr06 02-15-30 PM - 25Apr06 02-18-47 PM - Day 1   
activPAL Serial Number: 324DG404       
Start Time: 02:15 PM  25-
Apr-06 
       
Stop Time: 02:18 PM 25-Apr-
06 
       
Elapsed 
Time:  
00:03         
Date Hour Sit/Lie 
(min) 
Stand 
(min) 
Step 
(min
) 
sit/stand 
movement
s 
stand/sit 
movement
s 
No 
steps 
EE 
(MET.h) 
25-Apr-
06 
2:00 PM 0.8 0.9 1.5 1 1 148 0.127  
          
15s data for Activity profile for 324DG404 25Apr06 02-15-30 PM - 25Apr06 02-18-47 PM - Day 1  
activPAL Serial Number: 324DG404       
Start Time: 02:15 PM  25-Apr-
06 
       
Stop Time: 02:18 PM 25-Apr-
06 
       
Elapsed 
Time:  
00:03         
   no sit 1 period recorded during trial due to trial error not activity 
monitor error. 
Time Sitting 
(s) 
Standin
g (s) 
Steppin
g (s) 
Steps Energy Expenditure (MET.h)   
14:15:30 0 1.9 13.1 16 0.0112  -  start walk 1 14:15:30  
14:15:45 0 0 15 28 0.0162     
14:16:00 0 2.9 12.1 2  end walk 1 14;16:15 start sit 2   
14:16:15 0 15 0 0 0.0058 registers standing in this sit 2 
period 
14:16:30 0 0.3 14.7 30 0.0163 end sit 2 14:16:30 start walk 2  
14:16:45 0 6.8 8.2 16 0.0119 end walk 2 14:16:53 start 
stand 1  
14:17:00 0 15 0 0 0.0058     
14:17:15 5.3 9.7 0 0 0.0056 end stand 1 14:17:25 start sit 3  
14:17:30 15 0 0 0 0.0052     
14:17:45 8.8 1.4 4.8 10 0.0091 end sit 3 14:17:54 start walk 3    
14:18:00 0 0 15 32 0.0174     
14:18:15 6.4 1.9 6.7 14 0.0106 end walk 3 14:18:23 start sit 4   
14:18:30 15 0 0 0 0.0052 end sit 4 14:18:45   
 
 
 
 
 
 
 
 93
12.2.2 Participant no. 2  
Activity profile for participant 2 run 2 324DG404 19Apr06 10-24-56 AM - 19Apr06 10-29-13 AM - Day 1  
activPAL Serial Number: 324DG404        
Start Time: 10:25 AM  19-Apr-06        
Stop Time: 10:29 AM 19-Apr-06         
Elapsed 
Time:  00:04          
Date Hour 
Sit/Lie 
(min) 
Stand 
(min) 
Step 
(min) 
sit/stand 
movements 
stand/sit 
movements 
No 
steps 
EE 
(MET.h)  
19-Apr-06 10:00 AM 0.6 1.6 1.9 1 1 222 0.174   
           
15s data for Activity profile for participant 2 run 2 324DG404 19Apr06 10-24-56 AM - 19Apr06 10-29-13 
AM - Day 1 
activPAL Serial Number: 324DG404        
Start Time: 10:25 AM  19-Apr-06        
Stop Time: 10:29 AM 19-Apr-06         
Elapsed 
Time:  00:04          
           
Time Sitting (s) 
Standin
g (s) 
Steppin
g (s) Steps Energy Expenditure (MET.h)    
10:25:00 15 0 0 0 0.0052      
10:25:15 8.5 2.9 3.6 6 0.0069      
10:25:30 0 0 15 34 0.0178      
10:25:45 0 2.8 12.2 26 0.0155      
10:26:00 0 15 0 0 0.0058      
10:26:15 0 15 0 0 0.0058      
10:26:30 0 1.8 13.2 32 0.0169      
10:26:45 0 0 15 36 0.0187      
10:27:00 0 1.8 13.2 4 0.0078      
10:27:15 0 15 0 0 0.0058      
10:27:30 0 11.5 3.5 4 0.0073      
10:27:45 0 15 0 0 0.0058      
10:28:00 0 11.3 3.7 8 0.0086      
10:28:15 0 0 15 34 0.0182      
10:28:30 0 0 15 30 0.0164      
10:28:45 8.7 1.1 5.2 10 0.0094      
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12.3.3 Participant no.3 
 
Activity profile for 324DG404 Participant 3 run 1 03Apr06 04-05-54 PM - 03Apr06 04-17-39 PM 
- Day 1 
 
activPAL Serial Number: 324DG404       
Start Time: 04:06 PM  03-
Apr-06 
       
Stop Time: 04:17 PM 03-
Apr-06 
       
Elapsed 
Time:  
00:11         
Date Hour Sit/Lie 
(min) 
Stand 
(min) 
Step 
(min) 
sit/stand 
movements 
stand/sit 
movement
s 
No 
step
s 
EE 
(MET.h) 
03-Apr-
06 
4:00 
PM 
3.9 3.6 4.1 4 4 394 0.403  
          
15s data for Activity profile for 324DG404 Participant 3 run 1 03Apr06 04-05-54 PM - 03Apr06 04-
17-39 PM - Day 1 
activPAL Serial Number: 324DG404       
Start Time: 04:06 PM  03-Apr-
06 
       
Stop Time: 04:17 PM 03-Apr-
06 
       
Elapsed 
Time:  
00:11         
          
Time Sitting 
(s) 
Standing 
(s) 
Stepping 
(s) 
Step
s 
Energy Expenditure 
(MET.h) 
  
16:06:00 0 15 0 0 0.0058     
16:06:15 0 15 0 0 0.0058     
16:06:30 0 8.9 6.1 10 0.0088     
16:06:45 0 12.1 2.9 2 0.0072     
16:07:00 0 7.2 7.8 14 0.0108     
16:07:15 0 7.9 7.1 14 0.011     
16:07:30 0 6.3 8.7 18 0.0122     
16:07:45 0 0 15 30 0.0163     
16:08:00 0 14.1 0.9 0 0.0064     
16:08:15 0 15 0 0 0.0058     
16:08:30 0 10.5 4.5 8 0.0082     
16:08:45 0 0 15 30 0.0168     
16:09:00 0 0 15 28 0.0157     
16:09:15 4.9 2.6 7.5 6 0.0084     
16:09:30 15 0 0 0 0.0052     
16:09:45 15 0 0 0 0.0052     
16:10:00 15 0 0 0 0.0052     
16:10:15 15 0 0 0 0.0052     
16:10:30 15 0 0 0 0.0052     
16:10:45 15 0 0 0 0.0052     
16:11:00 15 0 0 0 0.0052     
16:11:15 15 0 0 0 0.0052     
16:11:30 3.5 1 10.5 18 0.0121     
16:11:45 0 0 15 26 0.0152     
16:12:00 0 6.1 8.9 12 0.0103     
16:12:15 0 15 0 0 0.0058     
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16:12:30 0 14.9 0.1 2 0.0059     
16:12:45 0 0 15 24 0.0145     
16:13:00 0 0 15 24 0.0146     
16:13:15 0 12.8 2.2 2 0.0071     
16:13:30 0 15 0 0 0.0058     
16:13:45 9.1 5.9 0 0 0.0055     
16:14:00 15 0 0 0 0.0052     
16:14:15 6.8 1.4 6.8 10 0.0089     
16:14:30 0 0 15 16 0.0119     
16:14:45 0 0 15 22 0.0132     
16:15:00 0 0 15 20 0.0135     
16:15:15 9.6 1.1 4.3 6 0.0078     
16:15:30 15 0 0 0 0.0052     
16:15:45 15 0 0 0 0.0052     
16:16:00 4.5 2.9 7.6 4 0.0068     
16:16:15 3.8 0.9 10.3 14 0.0111     
16:16:30 15 0 0 0 0.0052     
16:16:45 10.1 0.9 4 8 0.0082     
16:17:00 0 1.6 13.4 26 0.0146     
16:17:15 0 15 0 0 0.0058     
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 96
12.4.4 Participant no.4 
Activity profile for Participant number 4 324DG404 05Apr06 10-47-59 AM - 05Apr06 10-54-51 AM - Day 1  
activPAL Serial Number: 324DG404        
Start Time: 10:48 AM  05-Apr-06         
Stop Time: 10:54 AM 05-Apr-06         
Elapsed 
Time:  
00:06          
Date Hour Sit/Lie 
(min) 
Stand 
(min) 
Step 
(min) 
sit/stand 
moveme
nts 
stand/sit 
moveme
nts 
No steps EE 
(MET.h) 
 
05-Apr-
06 
10:00 
AM 
3 1.6 2.2 4 4 218 0.228   
           
15s data for Activity profile for Participant number 4 324DG404 05Apr06 10-47-59 AM - 05Apr06 10-54-51 
AM - Day 1 
activPAL Serial Number: 324DG404        
Start Time: 10:48 AM  05-Apr-06         
Stop Time: 10:54 AM 05-Apr-06         
Elapsed 
Time:  
00:06          
           
Time Sitting 
(s) 
Standing 
(s) 
Stepping 
(s) 
Steps Energy Expenditure (MET.h)    
10:48:00 0 15 0 0 0.0058   
10:48:15 0 15 0 0 0.0058      
10:48:30 8.4 3.3 3.3 6 0.0077 sit 1 starts here    
10:48:45 15 0 0 0 0.0052      
10:49:00 15 0 0 0 0.0052      
10:49:15 13.7 1.3 0 0 0.0053      
10:49:30 0 0.6 14.4 32 0.0169      
10:49:45 5 1.7 8.3 16 0.0119      
10:50:00 15 0 0 0 0.0052      
10:50:15 10.5 1.3 3.2 8 0.0079      
10:50:30 0 0 15 32 0.0175      
10:50:45 0 14.7 0.3 0 0.0061      
10:51:00 0 15 0 0 0.0058      
10:51:15 11.1 3.9 0 0 0.0054      
10:51:30 15 0 0 0 0.0052      
10:51:45 5.8 1.3 7.9 14 0.0106      
10:52:00 0 0 15 34 0.0175      
10:52:15 9.3 1 4.7 8 0.009      
10:52:30 15 0 0 0 0.0052      
10:52:45 15 0 0 0 0.0052      
10:53:00 15 0 0 0 0.0052      
10:53:15 11.4 2.4 1.2 4 0.0062      
10:53:30 0 0 15 10 0.0096      
10:53:45 0 0 15 24 0.0146      
10:54:00 0 0 15 16 0.0119      
10:54:15 0 2.6 12.4 14 0.0102      
10:54:30 0 15 0 0 0.0058      
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12.5.5 Participant no.5   
 
Activity profile for 324DG404 19Apr06 11-23-46 AM - 19Apr06 11-27-42 AM - Day 1   
activPAL Serial Number: 324DG404       
Start Time: 11:24 AM  19-Apr-06       
Stop Time: 11:27 AM 19-
Apr-06        
Elapsed 
Time:  00:03         
Date Hour 
Sit/Lie 
(min) 
Stand 
(min) 
Step 
(min) 
sit/stand 
movements
stand/sit 
movements 
No 
steps EE (MET.h) 
19-Apr-
06 
11:00 
AM 1.8 0.7 1.2 3 3 136 0.132  
          
15s data for Activity profile for 324DG404 19Apr06 11-23-46 AM - 19Apr06 11-27-42 AM - 
Day 1  
activPAL Serial Number: 324DG404       
Start Time: 11:24 AM  19-Apr-06       
Stop Time: 11:27 AM 19-
Apr-06        
Elapsed 
Time:  00:03         
          
Time 
Sitting 
(s) 
Standing 
(s) 
Stepping 
(s) Steps Energy Expenditure (MET.h)   
11:24:00 15 0 0 0 0.0052     
11:24:15 8.2 2.3 4.5 8 0.0083     
11:24:30 0 0 15 28 0.0157     
11:24:45 9.8 1.2 4 6 0.008     
11:25:00 15 0 0 0 0.0052     
11:25:15 6.1 1.2 7.7 16 0.0107     
11:25:30 0 0 15 22 0.0144     
11:25:45 0 13.9 1.1 2 0.0066     
11:26:00 0 15 0 0 0.0058     
11:26:15 14.2 0.8 0 0 0.0052     
11:26:30 15 0 0 0 0.0052     
11:26:45 0.6 1.6 12.8 28 0.0153     
11:27:00 0 0.8 14.2 26 0.0158     
11:27:15 12.7 2.3 0 0 0.0053     
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Appendix Number 13 
Analysis of the Data. 
 
Intra observer reliability  
Before the correlation between the data output from the activPAL 
monitor and the video occurs it must be ensured that the observer 
data is reliable.  
To ensure that the data gained from the video by the two observers 
was reliable, statistical analysis for intra observer reliability was carried 
out, between the two sets of observer results: 
1) The steps.     
2) The times taken for each event. 
 
The data from observer 1 and observer 2 for the number of steps 
were correlated against each other using Pearson’s Correlation and 
paired t-test. The data from observer 1 and 2 for each of the 
individual events were also correlated against each other using 
Pearson’s Correlation and paired t-test. (sit 2; sit 3; walk 1;walk 2; 
walk 3; stand 1).    
 
Reliability of the activPAL monitor. 
The reliability of the monitor was assessed by, the same monitor being 
used with the same subject, repeating the course seven times. 
Pearson’s Correlation and t-tests were then carried out on the number 
of steps undertaken for walk1, walk2 and walk3. Secondly Pearson’s 
correlation and t-tests occurred for the timings of the activities 
undertaken.        
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The Validity of the activPAL monitor. 
To examine the validity, the data obtained from the activPAL monitor 
was correlated against the data obtained from observer 1 and a t-test 
was undertaken. The intra correlation between the observers was high 
indicating that the discrepancies between the data obtained from 
observer 1 and observer 2 were minimal. This being the case it was 
decided to correlate the activPAL data against the data obtained from 
observer 1. The data obtained for the number of steps from the 
activPAL was also correlated against the data obtained from observer 
1. 
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Appendix 14 The raw data tables   
12.1 The intra-rater data tables for the observers 
Observer timings and counts comparison.       
          
Subject 1          
  Steve Martin  Steve Martin  Steve Martin 
  time 
(secs) 
Time 
(secs) 
 Time 
(secs) 
time  
(secs) 
Time 
(secs) 
Time 
(secs)  
 sit 1   walk 
1 
00:00:26 00:00:26 stand1 00:00:31 00:00:31 
 sit 2 00:00:32 00:00:32 walk 
2 
00:00:28 00:00:28    
 sit 3 00:00:30 00:00:31 walk 
3 
00:00:31 00:00:32    
 sit 4 00:00:31 00:00:31       
Total  00:02:04 00:02:05  00:01:25 00:01:26  00:00:31 00:00:31 
          
Subject 2          
  Steve Martin  Steve Martin  Steve Martin 
  time 
(secs) 
Time 
(secs) 
 Time 
(secs) 
Time 
 (secs) 
Time 
(secs) 
Time 
(secs)  
 sit 1   walk 
1 
00:00:30 00:00:31 stand1 00:00:32 00:00:38 
 sit 2 00:00:35 00:00:34 walk 
2 
00:00:34 00:00:30    
 sit 3 00:00:31 00:00:31 walk 
3 
00:00:41 00:00:40    
 sit 4 00:00:32 00:00:32       
Total  00:01:38 00:01:37  00:01:45 00:01:41  00:00:32 00:00:38 
          
Subject 3          
  Steve Martin  Steve Martin  Steve Martin 
  time 
(secs) 
Time 
(secs) 
 Time 
(secs) 
time  
(secs) 
Time 
(secs) 
Time 
(secs)  
 sit 1   walk 
1 
00:00:26 00:00:26 stand1 00:00:29 00:00:30 
 sit 2 00:00:31 00:00:31 walk 
2 
00:00:27 00:00:27    
 sit 3 00:00:29 00:00:31 walk 
3 
00:00:32 00:00:31    
 sit 4 00:00:30 00:00:31       
Total  00:01:30 00:01:33  00:01:25 00:01:24  00:00:29 00:00:30 
          
Subject 4          
  Steve Martin  Steve Martin  Steve Martin 
  time 
(secs) 
time(sec)  Time 
(secs) 
time  
(secs) 
Time 
(secs) 
Time 
(secs)  
 sit 1   walk 
1 
00:00:26 00:00:27 stand1 00:00:31 00:00:31 
 sit 2 00:00:30 00:00:30 walk 
2 
00:00:21 00:00:20    
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 sit 3 00:00:31 00:00:32 Walk  
3 
00:00:30 00:00:30    
 sit 4 00:00:31 00:00:31       
Total  00:01:32 00:01:33  00:01:17 00:01:17  00:00:31 00:00:31 
          
Subject 
5 
         
  Steve Martin  Steve Martin  Steve Martin 
  time 
(secs) 
Time 
(secs) 
 Time 
(secs) 
time  
(secs) 
Time 
(secs) 
Time 
(secs)  
 sit 1        walk 
1 
00:00:29 00:00:26 stand1 00:00:30 00:00:30 
 sit 2 00:00:30 00:00:31 walk 
2 
00:00:23   00:00:24   
 sit 3 00:00:30 00:00:31 walk 
3 
00:00:30 00:00:29    
 sit 4      
00:00:30 
00:00:31       
Total       
00:01:30 
00:01:33  00:01:22 00:01:19  00:00:30 00:00:30 
          
          
Participant 1         
  S M       
  No.Steps No. steps       
 walk 
1 
22 23       
 walk 
2 
21 21       
 walk 
3 
30 29       
Total  73 73       
Participant 2         
  S M       
  No.Steps No. steps       
 walk 
1 
33 33       
 walk 
2 
32 33       
 walk 
3 
41 41       
Total  106 107       
Participant 3         
  Steve Martin       
  No.Steps No. steps       
 walk 
1 
24 24       
 walk 
2 
24 24       
 walk 
3 
29 29       
 102
Total  77 77       
          
          
Participant 4         
  Steve Martin       
  No.Steps No. steps       
 walk 
1 
26 27       
 walk 
2 
21 22       
 walk 
3 
31 31       
Total  78 80       
          
Participant 5         
  Steve Martin       
  No.Steps No. steps       
 walk 
1 
22 23       
 walk 
2 
20 20       
 walk 
3 
28 28       
Total  70 71       
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14.2 The reliability data tables from the activPAL and the observer.  
 
The sit timings 
sit 2    sit 3   
Trial 
no. 
observer  activPAL  Trial 
no. 
observer activPAL 
1 00.00.30 00:00:32  1 00.00.29 00:00:29 
2 00.00.30 00:00:31  2 00.00.30 00:00:31 
3 00:00:32 00:00:31  3 00:00:30 00:00:30 
4 00.00.30 00:00:31  4 00.00.28 00:00:29 
5 00.00.31 00:00:33  5 00.00.30 00:00:30 
6 00.00.32 00:00:33  6 00.00.31 00:00:30 
7 00.00.31 00:00:31  7 00.00.31 00:00:31 
 
The walk timings 
walk 1    walk 2   
Trial 
no. 
observer  activPAL  Trial 
no. 
observer activPAL 
1 00.00.27 00:00:27  1 00.00.24 00:00:22 
2 00.00.27 00:00:21  2 00.00.23 00:00:23 
3 00:00:28 00:00:12  3 00:00:23 00:00:22 
4 00.00.26 00:00:24  4 00.00.25 00:00:27 
5 00.00.26 00:00:24  5 00.00.25 00:00:24 
6 00.00.26 00:00:24  6 00.00.24 00:00:23 
7 00.00.25 00:00:25  7 00.00.25 00:00:23 
 
walk 3   
Trial 
no. 
observer activPAL 
1 00.00.32 00:00:29 
2 00.00.32 00:00:29 
3 00:00:32 00:00:20 
4 00.00.35 00:00:35 
5 00.00.33 00:00:24 
6 00.00.34 00:00:31 
7 00.00.34 00:00:37 
 
The stand timings 
stand
1 
  
Trial 
no. 
observer activPAL 
1 00.00.31 00:00:33 
2 00.00.30 00:00:30 
3 00:00:31 00:00:32 
4 00.00.33 00:00:31 
5 00.00.31 00:00:32 
6 00.00.30 00:00:32 
7 00.00.29 00:00:31 
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The number of steps 
walk 1    walk 2   
Trial 
no. 
obser
ver 
activP
AL 
 Trial 
no. 
obser
ver 
activP
AL 
1 22 18  1 21 18 
2 22 15  2 21 18 
3 21 11  3 21 19 
4 22 22  4 22 22 
5 22 21  5 21 19 
6 22 21  6 21 19 
7 23 22  7 22 20 
 
walk 3   
Trial 
no. 
obser
ver 
activP
AL 
1 28 26 
2 29 27 
3 28 26 
4 30 31 
5 29 21 
6 30 31 
7 30 30 
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14.3 The validity data tables from the activPAL and observers. 
 
  
All walk data  
 activPAL Observer 
walk 1 00:00:45 00:00:46 
walk 2 00:00:23 00:00:23 
walk 3 00:00:30 00:00:29 
walk 1 00:00:33 00:00:31 
walk 2 00:00:41 00:00:30 
walk 3 00:00:39 00:00:40 
walk 1 00:00:25 00:00:26 
walk 2 00:00:26 00:00:27 
walk 3 00:00:32 00:00:31 
walk 1 00:00:24 00:00:27 
walk 2 00:00:19 00:00:20 
walk 3 00:00:32 00:00:30 
walk 1 00:00:26 00:00:26 
walk 2 00:00:25 00:00:24 
walk 3 00:00:28 00:00:29 
 
All sit data  
 activPAL Observer 
sit 2 00:01:00 00:00:59 
sit 3 00:00:29 00:00:30 
sit 2 00:00:35 00:00:34 
sit 3 00:00:29 00:00:31 
sit 2 00:00:31 00:00:30 
sit 3 00:00:31 00:00:32 
sit 2 00:00:33 00:00:30 
sit 3 00:00:32 00:00:32 
sit 2 00:00:32  00:00:31 
sit 3 00:00:30 00:00:31 
 
 
All stand data  
 activPAL Observer 
stand 1 00:00:32 00:00:31 
stand1 00:00:29 00:00:38 
stand1 00:00:31 00:00:30 
stand1 00:00:34 00:00:31 
stand1 00:00:30 00:00:30 
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All number steps data 
walk 1 23 23 
walk 2 23 21 
walk 3 28 29 
walk 1 33 33 
walk 2 36 33 
walk 3 41 41 
walk 1 23 24 
walk 2 21 24 
walk 3 28 29 
walk 1 24 27 
walk 2 20 22 
walk 3 28 31 
walk 1 21 23 
walk 2 20 20 
walk 3 27 28 
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Appendix No 15 THE SPSS ANALYSIS STATISTICS OUTPUT 
 
15.1 Intra-rater observer statistics 
 
13.1.1 Correlation and t-test for all sit timings 
Correlations 
 
 Correlations 
 
  Steve Martin 
Pearson Correlation 1 .884(**) 
Sig. (1-tailed)   .000 
Steve 
N 15 15 
Pearson Correlation .884(**) 1 
Sig. (1-tailed) .000   
Martin 
N 15 15 
**  Correlation is significant at the 0.01 level (1-tailed). 
 
T-Test 
 
Paired Samples Statistics
30.87 15 1.407 .363
31.33 15 .900 .232
Steve
Martin
Pair
1
Mean N Std. Deviation
Std. Error
Mean
 
 
 
 Paired Samples Correlations 
 
  N Correlation Sig. 
Pair 1 Steve & Martin 15 .884 .000 
 
 
 Paired Samples Test 
 
Paired Differences 
95% Confidence 
Interval of the 
Difference 
  Mean 
Std. 
Deviation 
Std. 
Error 
Mean Lower Upper t df 
Sig. (2-
tailed) 
Pair 1 Steve - Martin -.467 .743 .192 -.878 -.055 -2.432 14 .029 
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15.1.2 Correlation and t-test for all stand timings.  
 
nb not statistically significant as more than 0.05 – however t-test 
below reveals that there is not  a significant difference between the 
means of 30.50 and 32.25 
Correlation 
 
 Correlations 
 
  Steve Martin 
Pearson Correlation 1 .886(**) 
Sig. (1-tailed)   .000 
Steve 
N 12 12 
Pearson Correlation .886(**) 1 
Sig. (1-tailed) .000   
Martin 
N 12 12 
**  Correlation is significant at the 0.01 level (1-tailed). 
 
 
T-test 
 
  
 Paired Samples Statistics 
 
  Mean N Std. Deviation 
Std. Error 
Mean 
Steve 30.83 12 1.528 .441 Pair 1 
Martin 31.33 12 .985 .284 
 
 
 
 Paired Samples Correlations 
 
  N Correlation Sig. 
Pair 1 Steve & Martin 12 .886 .000 
 
 Paired Samples Test 
 
Paired Differences 
95% Confidence 
Interval of the 
Difference 
  Mean 
Std. 
Deviation 
Std. 
Error 
Mean Lower Upper t df 
Sig. (2-
tailed) 
Pair 1 Steve - Martin -.500 .798 .230 -1.007 .007 -2.171 11 .053 
 
 
 109
15.1.3 Correlation and t-test for walk timings 
          Correlations 
  
 Correlations 
 
  Steve Martin 
Pearson Correlation 1 .952(**) 
Sig. (1-tailed)   .000 
Steve 
N 15 15 
Pearson Correlation .952(**) 1 
Sig. (1-tailed) .000   
Martin 
N 15 15 
**  Correlation is significant at the 0.01 level (1-tailed). 
 
 
T-Test 
 
  
 Paired Samples Statistics 
 
  Mean N Std. Deviation 
Std. Error 
Mean 
Steve 28.93 15 4.758 1.228 Pair 1 
Martin 28.47 15 4.454 1.150 
 
 
 
 
 Paired Samples Correlations 
 
  N Correlation Sig. 
Pair 1 Steve & Martin 15 .952 .000 
 
 
 Paired Samples Test 
 
Paired Differences 
95% Confidence 
Interval of the 
Difference 
  Mean 
Std. 
Deviation 
Std. 
Error 
Mean Lower Upper t df 
Sig. (2-
tailed) 
Pair 1 Steve - Martin .467 1.457 .376 -.340 1.274 1.240 14 .235 
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15.1.4 Correlations and t-test for step count data  
 
Descriptive Statistics
26.93 5.837 15
27.20 5.685 15
S
M
Mean Std. Deviation N
 
 
Correlations
1 .995**
.000
15 15
.995** 1
.000
15 15
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
S
M
S M
Correlation is significant at the 0.01 level
(1 il d)
**. 
 
 
T-Test 
 
Paired Samples Statistics
26.93 15 5.837 1.507
27.20 15 5.685 1.468
S
M
Pair
1
Mean N Std. Deviation
Std. Error
Mean
 
 
Paired Samples Correlations
15 .995 .000S & MPair 1
N Correlation Sig.
 
 
Paired Samples Test
-.267 .594 .153 -.595 .062 -1.740 14 .104S - MPair 1
Mean
Std.
Deviation
Std. Error
Mean Lower Upper
95% Confidence
Interval of the
Difference
Paired Differences
t df
Sig.
(2-tailed)
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15.1.5 Correlations and t-test for observer S and observer M  
for total observation data.   
 
Descriptive Statistics
30.04 3.616 28
30.21 3.775 28
S
M
Mean Std. Deviation N
 
 
Correlations
1 .895**
.000
28 28
.895** 1
.000
28 28
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
S
M
S M
Correlation is significant at the 0.01 level
(1 il d)
**. 
 
 
T-Test 
 
Paired Samples Statistics
30.04 28 3.616 .683
30.21 28 3.775 .713
S
M
Pair
1
Mean N Std. Deviation
Std. Error
Mean
 
 
Paired Samples Correlations
28 .895 .000S & MPair 1
N Correlation Sig.
 
 
Paired Samples Test
-.179 1.701 .321 -.838 .481 -.556 27 .583S - MPair 1
Mean
Std.
Deviation
Std.
Error
Mean Lower Upper
95% Confidence
Interval of the
Difference
Paired Differences
t df
Sig.
(2-tailed)
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15.1.6 Comment on intra rater statistics. 
The statistical output reveals without doubt that there is a close 
correlation between the observations made by observer ‘M’ and 
observer ‘S’. Only the stand timings correlation output is not 
statistically significant, however the t-test reveals that there is not a 
significant difference between the means of 30.50 and 32.25. It can 
be concluded that the observations are accurate. Due to the excellent 
correlation of the observations it was decided to correlate the activPAL 
data against observer ‘M’ data when determining the reliability of the 
activPAL monitor.    
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15.2 The Reliability Statistics 
15.2.1 The reliability of the Activity Timing.  
 
Correlations 
 
Correlations
1 .974**
.001
6 6
.974** 1
.001
6 6
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
run1
run2
run1 run2
Correlation is significant at the 0.01 level
(1 il d)
**. 
 
 
T-Test 
 
Paired Samples Statistics
28.83 6 2.927 1.195
28.67 6 3.204 1.308
run1
run2
Pair
1
Mean N Std. Deviation
Std. Error
Mean
 
 
Paired Samples Correlations
6 .974 .001run1 & run2Pair 1
N Correlation Sig.
 
 
 
 Paired Samples Test 
 
Paired Differences 
95% Confidence 
Interval of the 
Difference 
  Mean 
Std. 
Deviation
Std. Error 
Mean Lower Upper t df 
Sig. (2-
tailed) 
Pair 1 run1 - 
run2 .167 .753 .307 -.623 .957 .542 5 .611
 
 
 
 
 114
15.2.2 The Reliability of the Step Counts 
 
Correlations 
 
Correlations
1 1.000**
.006
3 3
1.000** 1
.006
3 3
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
run1
run2
run1 run2
Correlation is significant at the 0.01 level
(1 il d)
**. 
 
 
T-Test 
 
Paired Samples Statistics
23.67 3 3.786 2.186
24.00 3 4.359 2.517
run1
run2
Pair
1
Mean N Std. Deviation
Std. Error
Mean
 
 
Paired Samples Correlations
3 1.000 .011run1 & run2Pair 1
N Correlation Sig.
 
 
Paired Samples Test
-.333 .577 .333 -1.768 1.101 -1.000 2 .423run1 - run2Pair 1
Mean
Std.
Deviation
Std.
Error
Mean Lower Upper
95% Confidence
Interval of the
Difference
Paired Differences
t df
Sig.
(2-tailed)
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15.3 The Validity Statistics. 
13.3.1 Validity Correlations All Sit Data.  
 
Descriptive Statistics
34.20 9.247 10
34.00 8.869 10
activPAL
observer
Mean Std. Deviation N
 
 
Correlations
1 .988**
.000
10 10
.988** 1
.000
10 10
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
activPAL
observer
activPAL observer
Correlation is significant at the 0.01 level (1-tailed).**. 
 
 
T-Test 
 
Paired Samples Statistics
34.20 10 9.247 2.924
34.00 10 8.869 2.805
activPAL
observer
Pair
1
Mean N Std. Deviation
Std. Error
Mean
 
 
Paired Samples Correlations
10 .988 .000activPAL & observerPair 1
N Correlation Sig.
 
 
Paired Samples Test
.200 1.476 .467 -.856 1.256 .429 9 .678activPAL - observerPair 1
Mean
Std.
Deviation
Std.
Error
Mean Lower Upper
95% Confidence
Interval of the
Difference
Paired Differences
t df
Sig.
(2-tailed)
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15.3.2 Pearson Correlation and t-test for all stand data. 
 
Descriptive Statistics
31.20 1.924 5
32.00 3.391 5
activPAL
observer
Mean Std. Deviation N
 
 
Correlations
1 -.537
.176
5 5
-.537 1
.176
5 5
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
activPAL
observer
activPAL observer
 
 
T-Test 
 
[DataSet0]  
 
Paired Samples Statistics
31.20 5 1.924 .860
32.00 5 3.391 1.517
activPAL
observer
Pair
1
Mean N Std. Deviation
Std. Error
Mean
 
 
Paired Samples Correlations
5 -.537 .351activPAL & observerPair 1
N Correlation Sig.
 
 
Paired Samples Test
-.800 4.712 2.107 -6.650 5.050 -.380 4 .723activPAL - observerPair 1
Mean
Std.
Deviation
Std.
Error
Mean Lower Upper
95% Confidence
Interval of the
Difference
Paired Differences
t df
Sig.
(2-tailed)
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15.3.3 Correlations for Validity All walk Data 
Descriptive Statistics
29.87 7.249 15
29.27 6.475 15
activPAL
observer
Mean Std. Deviation N
 
Correlations
1 .899**
.000
15 15
.899** 1
.000
15 15
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
activPAL
observer
activPAL observer
Correlation is significant at the 0.01 level (1-tailed).**. 
 
 
T-Test 
Paired Samples Statistics
29.87 15 7.249 1.872
29.27 15 6.475 1.672
activPAL
observer
Pair
1
Mean N Std. Deviation
Std. Error
Mean
 
Paired Samples Correlations
15 .899 .000activPAL & observerPair 1
N Correlation Sig.
 
Paired Samples Test
.600 3.180 .821 -1.161 2.361 .731 14 .477activPAL - observerPair 1
Mean
Std.
Deviatio
n
Std.
Error
Mea
n Lower Upper
95% Confidence
Interval of the
Difference
Paired Differences
t df
Sig.
(2-tailed)
 
 
Paired Samples Statistics
29.87 15 7.249 1.872
29.27 15 6.475 1.672
activPAL
observer
Pair
1
Mean N Std. Deviation
Std. Error
Mean
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15.3.4 Validity Correlations and t-test for all step data. 
 
Descriptive Statistics
26.40 6.197 15
27.20 5.685 15
activPAL
observer
Mean Std. Deviation N
 
 
Correlations
1 .961**
.000
15 15
.961** 1
.000
15 15
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
activPAL
observer
activPAL observer
Correlation is significant at the 0.01 level (1-tailed).**. 
 
 
T-Test 
 
Paired Samples Statistics
26.40 15 6.197 1.600
27.20 15 5.685 1.468
activPAL
observer
Pair
1
Mean N Std. Deviation
Std. Error
Mean
 
 
Paired Samples Correlations
15 .961 .000activPAL & observerPair 1
N Correlation Sig.
 
 
Paired Samples Test
-.800 1.740 .449 -1.764 .164 -1.780 14 .097activPAL - observerPair 1
Mean
Std.
Deviation
Std.
Error
Mean Lower Upper
95% Confidence
Interval of the
Difference
Paired Differences
t df
Sig.
(2-tailed)
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Appendix Number 16. 
The calculations of the cadence of participants 1 to 5 
 
 
CALCULATIONS FOR CADENCE OF PARTICIPANTS 1 - 5    
         
Participant 1 Cadence (Steps  per minute)  Participant 4 Cadence (Steps per minute) 
time 
(secs) 
No steps    time 
(secs) 
No 
Steps 
  
45 23    24 24   
23 23    19 20   
30 28    32 28   
         
98 second = 1.63 minutes   Cadence =No steps/minute = 72/1.25= 57.6 
         
Cadence = 74/1.63 = 45.40 steps/minute  Participant no 5 Cadence (Steps per minute) 
     time 
(secs)  
No steps   
Participant 2 Cadence (Steps per minute)  26 21   
time 
(secs) 
No steps    25 20   
33 33    28 27   
41 36        
39 41    Cadence = No steps/minute = 68/1.32 = 51.5 
         
Cadence = No steps /minutes = 110/1.88 =58.51     
          
Participant 3 Cadence (Steps per minute)      
time 
(secs) 
No steps        
25 23        
26 21        
32 28        
         
Cadence = No steps/minute = 72/1.38 = 
52  
     
         
Cadence ranges from 45.4 to 58.5 steps per 
minute 
    
 
 
 
 
 
 
 
 
